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The issue of how to test and ultimately regulate tobacco products represents a critical 
challenge for the public health community. Although the current international testing 
regime for conventional cigarettes is widely acknowledged to be seriously flawed, there 
is a lack of data to guide potential alternatives, particularly in the area of human puffing 
behaviour. The current study sought to: 1) collect naturalistic measures of smoking 
behaviour, 2) examine the extent to which levels of tar, nicotine, and carbon monoxide 
from each of five testing protocols were associated with measures of nicotine uptake 
among smokers, and 3) examine the validity of self-report measures of smoking 
behaviour. These questions were examined through two different studies. First, a field 
study of smoking behaviour was conducted with 59 adult smokers, who used a portable 
device to measure smoking topography over the course of 3 one-week trials. Participants 
were asked to smoke their usual “regular-yield” brand through the device for Trial 1 and 
again, 6 weeks later, at Trial 2. Half the subjects were then randomly assigned to smoke a 
“low-yield” brand for Trial 3. The smoke intake and constituent yield of each brand was 
then tested under five testing protocols: ISO, Massachusetts, Canadian, a Compensatory 
protocol, and a Human Mimic regime. Participants also completed self-report measures 
of puffing behaviour at recruitment and immediately following each of the three one-
week smoking trials. Several of these self-report measures were subsequently included in 
the Waves 2 and 3 of the International Tobacco Control Policy Evaluation (ITC) 
Survey—an international cohort survey of adult smokers from Canada, Australia, the US, 
and the UK.  
 
The results of the field study indicate a high degree of stability in puffing behaviour 
within the same smoker over time, but considerable variability between smokers, 
including those smoking the same brand. Puffing behaviour was strongly associated with 
cotinine levels, particularly when included in an interaction term with cigarettes per day 
(Part r = .50, p<.001). Smokers who were switched to a “low-yield” cigarette increased 
their total smoke intake per cigarette by 40% (p=.007), with no significant change in their 
in salivary cotinine levels.  
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The results indicate systematic differences between human puffing behaviour and the 
puffing regimes used by machine testing protocols. The puffing behaviour observed 
among participants during the one-week smoking trials was significantly more intense 
than the puffing parameters of the ISO and Compensatory testing regimes. When 
cigarette brands were machine tested using participants’ actual puffing behaviour, the 
results suggest that participants ingested two to four times the level of tar, nicotine, and 
carbon monoxide indicated by the ISO regime, and twice the amounts generated by the 
Compensatory regime for “regular-yield” brands. The Canadian and Massachusetts 
regimes produced yields much closer to the “Human Mimic” yields, although nowhere 
near a maximum or intense standard, as they were designed to do. Only the nicotine 
yields from the Human Mimic regime were correlated with measures of nicotine uptake 
among smokers, and only moderately so (Part r = .31, p=.02).  
 
Self-report measures of puffing behaviour collected during the field study were 
moderately correlated with physiological measures of puffing and exposure. Self-report 
measures of puff depth and puff number showed some promise as predictors of salivary 
cotinine, although the results are characterized by inconsistencies across models. The 
self-report measures included in the ITC survey were only weakly associated with age 
and cigarettes per day, with modest between-country differences.  
 
Overall, this research highlights the importance of puffing behaviour as a determinant of 
smoke exposure, and provides strong evidence of compensatory smoking for “low-yield” 
brands. The findings also highlight the variability in human smoking behaviour and the 
limitations associated with machine testing protocols. Perhaps most important, the 
findings underscore the immediate need to revise the ISO protocol, which systematically 
underestimates smoking behaviour among humans and exaggerates differences between 
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Tobacco use has been recognized by the World Health Organization as the leading cause 
of death and disability in the world.1  To date, more than two dozen different smoking-
related diseases have been identified and the list of known health effects continues to 
grow. 2  Worldwide, more than 5 million people die from tobacco use each year. Based 
upon current rates of smoking, the health and economic burden of tobacco use will 
increase dramatically in the coming decades: of all the people alive today, more than 500 
million are projected to die from smoking-related disease.3   
 
In Canada, the prevalence of smoking has decreased from a high of more than 50% in 
1965, to less than 20% today.4  Although this decline represents a major public health 
achievement, over 5 million Canadians continue to smoke, and tobacco use remains the 
primary cause of preventable death among Canadians.5 Thus, whatever policies have 
already been implemented, there is a need for even stronger policy alternatives.    
 
Reducing the prevalence of smoking remains the primary goal of tobacco control policy. 
At the same time, there is an implicit understanding within the tobacco control 
community that not even the best regulatory framework will succeed in completely 
eradicating smoking. Moreover, in countries such as Canada, further declines in 
prevalence are likely to be more gradual and progressively more difficult to achieve as 
the number of “hardcore” smokers increases as a proportion of all tobacco users.  
 
These realities have sparked growing discussion of so-called “harm-reduction” measures 
that promote the use of less toxic tobacco products as an alternative to abstinence. In 
other words, if hardcore smokers cannot be convinced to abandon tobacco use, there may 
be considerable public health benefit to having them switch to less hazardous tobacco 
products, such as smokeless tobacco or the next generation of potentially-reduced harm 
products (PREP’s) that heat, rather than combusted tobacco.  
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The merits of such an approach remain the source of much controversy and debate within 
the tobacco control community. 6,7 Yet, regardless of whether or not regulators pursue 
harm reduction policies that promote less toxic tobacco products or more traditional 
policies that restrict the toxicity of conventional cigarettes, there is an immediate need for 
valid testing protocols capable of assessing toxicity.  
 
To date, regulators and tobacco control advocates lack an effective means with which to 
measure the toxicity of cigarettes. The issue is not simply one of legal jurisdiction or 
regulatory authority, but one of science. In Canada, for example, the government already 
has complete authority to regulate how cigarettes are designed.8  Nevertheless, Canada 
has yet to implement any restrictions on how tobacco products are manufactured, largely 
because the government lacks appropriate testing standards to ensure that any such 
restrictions would succeed in reducing health risks, and would not be circumvented by 
tobacco manufacturers in some unforeseen fashion. As a consequence, tobacco products 
remain among the least regulated consumer products and are subject to fewer restrictions 
than pharmaceutical products, prepared foods, and virtually every other household 
product available to Canadians. In fact, there are only a handful of jurisdictions in the 
world that have set any restrictions on the constituents, emissions, or design of tobacco 
products. 
 
The issue of how to test and ultimately regulate tobacco products represents a critical 
challenge for the public health community. A poor regulatory testing protocol would 
confer little or no benefit to consumers, insulate the tobacco industry from culpability, 
and provide false assurances to consumers and regulators. Maintaining the status quo, 
however, is equally unacceptable. A failure to establish new testing standards and to 
pursue meaningful reductions in cigarette toxicity is not only a missed opportunity, but 
perpetuates the untenable situation, whereby the most lethal consumer product in history 
is virtually unregulated.  
 
The proposed research seeks to improve the evidence base for evaluating the toxicity of 
tobacco products. In particular, this research will: 1) review both independent and 
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tobacco industry studies of testing protocols and smoking behaviour, 2) measure puffing 
behaviour among smokers in their “natural” environment, and 3) evaluate the extent to 
which existing cigarette testing protocols are valid reflections of human smoking.  
 
1.1 Cigarette Testing Protocols 
 
Cigarette smoke is a complex mixture of over 4,000 chemicals.9  Since its inception, the 
tobacco industry has recognized the need for a standardized means of measuring these 
chemicals, not only to assess their health risks, but also to understand the reinforcing 
properties of different tobacco blends and product designs. In 1934, J.A. Bradford from 
the American Tobacco Company reviewed the different approaches that were being used 
at the time and proposed a smoking apparatus and a standard puffing regime to test 
smoke constituents.10  By 1930, this technique was widely adopted and formed the basis 
for the Cambridge Filter Method, which would become the official testing protocol for 
CORESTA, the international association of tobacco industry researchers.11 
 
Until 1966, cigarette testing and the reporting of smoke constituents was the 
responsibility of tobacco manufacturers. However, the release of the first U.S. Surgeon 
General’s report on smoking, published in 1964, increased public pressure on regulatory 
authorities to establish independent testing standards for all products. In response, the 
U.S. Federal Trade Commission (FTC) made only minor changes to the Cambridge Filter 
Method before adopting the industry standard as its official testing protocol in 1967. The 
same protocol was adopted soon after by the International Standards Organization (ISO) 
for use in countries outside the United States, such as Canada.12  
 
The “standard” FTC / ISO protocol tests cigarettes using a smoking machine that “puffs” 
on the filtered end of cigarettes through the suction of a pump. The cigarettes are smoked 
according to a standardized puffing regime: the pump draws 35ml puffs for two seconds, 
once per minute, until the lit end reaches a fixed distance from the cigarette filter. (Note 
that the FTC/ISO protocols use the same puffing regime that was “arbitrarily” selected by 
Bradford, in 1936.) With each puff, the mainstream smoke –the smoke drawn through the 
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filtered end of the cigarette— passes through the smoking port and through filter pads. 
These filter pads collect the particulate matter (the solid and liquid matter from tobacco 
smoke), while gases pass through the filter pad into collection bags. Various chemical 
and physical separation techniques are then used to isolate and quantify the individual 
chemical constituents in the smoke.13  
 
Figure 1. Filtrona smoking machine 
 
 
At present, these testing protocols are mandatory for cigarettes sold in most jurisdictions, 
including Canada, the U.S., and the European Union. In most of these jurisdictions, 
tobacco manufacturers are required to report three main constituents, or smoke “yields”: 
nicotine, carbon monoxide (CO), and tar –a “summary” measure of the total particulate 
matter after nicotine and water are removed. In many countries, tar and nicotine yields 
are reported directly to consumers either via cigarette packs or as part of warning labels 
that accompany print advertisements. Several jurisdictions also require tobacco 
manufacturers to report a more comprehensive list of chemicals. In Canada, for example, 
tobacco manufacturers must report emission data for more than 40 different chemicals.8   
 
1.2 Factors that Influence Smoke Constituents 
 
The constituents in cigarette smoke are determined by a complex set of product 
characteristics, including the tobacco blend, additives, and design features such as filter 
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ventilation and paper porosity.14 Tobacco manufacturers developed many of these design 
changes in the 1950’s in response to growing pressure from public health authorities to 
reduce the machine-determined tar yields of cigarettes. The impact of these design 
features on nicotine and tar yields is illustrated in Figure 2.  
 
Figure 2. Sales-weighted tar and nicotine values for U.S. cigarettes as measured using 
the FTC method 1954-199815 
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Prior to 1950, the vast majority of cigarettes were unfiltered. The introduction of filters 
represents the most significant design change during this period and had a substantial 
impact on cigarette yields. As the proportion of filtered cigarettes increased over the 
following decade, there was a sharp decline in the average tar yield of cigarettes, as 
depicted in Figure 2.  
 
The introduction of filter ventilation and expanded tobacco in the 1960’s and 70’s was 
responsible for further declines in cigarette yields. Filter ventilation is achieved by 
cutting small perforations into the paper wrapping the filter. These perforations are 
designed to sit outside the smoking port when cigarette yields are tested (as depicted in 
Figure 3), but in locations where the lips or fingers of the smoker can easily cover the 
holes. When the holes are uncovered and the low draw rates specified by the ISO 
protocol are used, air is drawn into the filter through the vent holes, diluting the smoke 
coming through the rod of tobacco and lowering the machine-measured tar values. When 
the vent holes are covered or when the smoker draws more rapidly on the cigarette, much 
more of the puff volume is composed of smoke drawn through the rod of tobacco and 
much less is composed of air drawn from the ventilation holes. The result is a dramatic 
rise in the tar and nicotine delivered to the smoker by the cigarette. As Figure 3 
illustrates, the vent holes are largely imperceptible to the naked eye. 
 
Figure 3. Filter ventilation 
         
A. Filter “vent-hole” perforations                      B. Position of vent-holes outside the port 
of the FTC smoking machine. 
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1.3 Puffing Behaviour and Behavioural “Compensation” 
 
Filter ventilation and other design changes had a substantial effect on the machine-
smoked yields; however, they also changed how cigarettes were smoked. Indeed, the 
changes in cigarette design over the past 50 years highlight the critical difference 
between human smoking and the “standard” puffing behaviour of the smoking machine. 
This phenomenon is best illustrated by examining the role of nicotine in smoking 
behaviour.   
 
Nicotine is the principal addictive ingredient in cigarettes and the driving force behind 
smoking behaviour.16  Smokers attempt to maintain a relatively constant level of nicotine 
in their bodies and alter their smoking behaviour in order to regulate this level throughout 
the day.17,18,19  Smokers do so by varying the number and the timing of cigarettes they 
smoke, as well as by varying their intake from each cigarette. Indeed, given that the 
average smoker consumes only 30% of the tobacco available in each cigarette, there is 
considerable opportunity for smokers to regulate their intake by changing the number, 
size, and velocity of puffs.20  In fact, smokers typically alter their puffing behaviour even 
during the course of a single cigarette in response to the sensory cues of smoking and the 
immediate pharmacological effects of nicotine.21  
 
One important implication is that individuals will adjust their smoking behaviour to 
compensate for different nicotine levels between products.17,22  Independent research has 
demonstrated that smokers of low yield cigarettes take larger puffs, more puffs per 
cigarette, and puffs with greater flow rates than smokers of “medium” or “high” nicotine-
yield cigarettes.16,23,24,25, 26  Indeed, changes in puffing behaviour, rather than vent-hole 
blocking, are the primary form of behavioural compensation for “low yield” cigarettes.27  
Industry research, described in their internal documents, comes to the same conclusions. 
One study conducted by British American Tobacco (BAT) on smokers who were 
switched to a lower nicotine cigarette reported that: “Changes in the number, duration 
and volume of puffs were noted, as well as butt length and pressure drop differences. In 
each case, the smoker adjusted his smoking habits in order to duplicate his normal 
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cigarette intake.” 28  Although the tobacco industry has yet to publicly acknowledge the 
extent to which smokers compensate for nicotine, Colin Grieg, a senior BAT researcher, 
summarized industry research on compensation as follows: “Many people will tell you 
authoritatively that, on sound statistical analysis of well designed experiments, low tar 
smokers do not compensate. Rubbish.” 29 
 
Smokers’ tendency to compensate means that the low tar and nicotine yields obtained 
from machine testing protocols may not be valid for human smokers. Yet, the limitations 
of the testing protocols are not confined to “low-yield” products. Rather, widespread 
design changes such as filter ventilation have implications for understanding puffing 
behaviour at the population-level of smokers. Indeed, such design changes appear to have 
shifted the “normal” parameters of puffing behaviour toward more intensive smoking. 
For example, one BAT researcher noted:  "We have found a trend within the department 
for smokers to increase the volume of smoke drawn from cigarettes as the standard 
deliveries have been reduced by manufacturers." 30  Although it is not apparent whether 
puffing behaviour among human smokers was ever similar to the “standard” ISO and 
FTC machine puffing regimes, the discrepancy between the two continues to grow. The 
size of this discrepancy and the actual parameters of human puffing behaviour are 
important not only to understand compensation, but also to determine the validity of the 
ISO puffing regime and the validity of the constituent yields that are reported to 
regulators and consumers.  
 
 
1.4 Parameters of Human Puffing Behaviour 
 
Human puffing behaviour will inevitably be more variable than any machine-based 
testing protocol; yet the issue is not simply whether human smoking is more variable, but 
whether it is systematically different than the testing protocols. A recent review of BAT 
research found six studies that compared measures of puffing behaviour among humans 
with the ISO puffing regime for the same cigarette brands. In each of the six studies, 
every parameter observed among human smokers –including puff volume, puff 
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frequency, puff number, and flow rate— was greater than the ISO puffing 
regime.31,32,33,34,35,36  Indeed, BAT research suggests that human smokers typically draw 
puff volumes almost twice as large as the ISO smoking machine (50-70ml vs. 35 ml, 
respectively), and at twice the rate as the ISO regime (every 30 seconds vs. every 60 
seconds). Overall, human smokers typically inhale twice the total volume of cigarette 
smoke as the ISO smoking machine.34, 37  David Creighton, a senior BAT researcher, 
commented on the systematic differences between human puffing behaviour and the ISO 
protocol in 1977:  “Of the 165 R&D smokers screened with profile recording units, there 
are fewer than 20% who take puffs of an average volume less than 35ml. Fifty percent 
take puffs that average 35-55ml and the remaining smokers take even larger puff volumes 
on their regular brands.”38  
 
Even taking into account the natural variations in puffing behaviour across smokers and 
different brands, the evidence is clear, as indicated in this BAT document: “Smoking 
pattern data have been recorded from several hundreds of smokers in Southampton 
[England]. No smoker yet has been observed who smokes with the same pattern as a 
smoking machine.”17,33  Therefore, the flaws of the current testing regimes are not limited 
only to smokers compensating for low yield products, but are present for virtually every 
smoker. These industry findings are consistent with those of independent researchers, 
which has found standard puffing regimes to underestimate the volume, frequency and 




1.5 Implications of Puffing Behaviour on Cigarette Deliveries and Health Risks 
 
Puffing behaviour has important implications for understanding the health risks of 
tobacco products. As Dr. Roe, a senior medical consultant to BAT noted: “Perhaps the 
most important determinant of the risk to health or to a particular aspect of health is the 
extent to which smoke is inhaled by smokers. If so, then deeply inhaled smoke from low 
tar delivery cigarettes might be more harmful than uninhaled smoke from high tar 
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cigarettes.”42 Indeed, even modest differences in puffing behaviour can have a significant 
impact upon the tar and nicotine delivered to smokers.  
 
Variations in puff volume and puff frequency—the two components of the total smoke 
intake— have the greatest impact on cigarette yields.31  The velocity of a puff, or “flow 
rate” also has implications for nicotine and tar yields.43  For example, greater flow rates 
increase cigarette yields by reducing the proportion of diluted air entering via the filter 
vent-holes and increasing the concentration of the smoke in each puff.43,44  Greater flow 
rates may also increase the “free” versus “bound” nicotine ratio45, which increases the 
bioavailability of nicotine and, ultimately, the addictiveness of a product.46  Puffing 
behaviour may also affect the relative amounts of tar and nicotine in mainstream tobacco 
smoke: “Clearly, the absolute deliveries will be different….Perhaps more importantly, 
though, the ratio of components within the smoke may be different.”21 For example, the 
tar/nicotine ratio may decrease under greater puff volumes, as the available nicotine is 
diluted by a greater production of tar.21  Finally, nicotine and tar deliveries increase with 
each subsequent puff due to reduced filtration by the shortening tobacco rod and because 
there is less diluting air coming through the cigarette paper and more air coming through 
the coal.47 
 
Given the differences between human puffing behaviour and the ISO puffing regime, 
described in the previous section, what are the implications for cigarette deliveries? The 
tobacco industry has conducted numerous studies that compare the machine-smoked 
yields generated under the ISO puffing regime (i.e. 35ml puffs, once per minute), with 
machine-smoked yields generated from actual puffs recorded from humans smoking the 
same brand. (In other words, the smoking machine is programmed to mimic the average 
puffing behaviour of a group of smokers.) A recent review of these studies found that the 
ISO protocol systematically underestimated the yields obtained by human smokers in 
every case.48 The systematic differences between human puffing and the ISO regime 
were large enough that BAT researchers began to question the utility of the ISO protocol 
for testing its own products. As a BAT position paper on smoking behaviour recently 
noted, “If a smoker forms a sensoric evaluation on a product after taking 70ml puffs 
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every 30 seconds, then it may not be appropriate to compare this with the chemistry of 
smoke generated by machine through puffing 35ml every 60 seconds.”21  C. McBride, an 
Imperial Tobacco scientist, summarized this data by noting that, one can “reasonably 
conclude that virtually all smokers are receiving substantially higher deliveries.”44 
 
Overall, the ISO tar and nicotine levels currently bear little or no relation to the actual 
levels of tar and nicotine delivered to smokers. 49,50,51  In fact, many of the changes in 
cigarette design that reduced machine-measured tar yields are responsible for this 
dissociation. Most important, the dramatic reduction in yields depicted in Figure 2 have 
failed to yield any significant public health benefit. Indeed, mortality rates from smoking 




1.6 Product Strategy and Testing Protocols 
 
The discrepancy between the ISO yields and the actual nicotine and tar delivered to 
human smokers is not simply an historical accident, but exists by careful design. Early 
efforts to develop genuinely low-tar cigarettes resulted in a product that few smokers 
were interested in using and led many to quit.54 It became clear to tobacco manufacturers 
that there was a trade-off between reducing the harmfulness of their products and 
maximizing their market-share.  The solution lay in smokers’ tendency to compensate 
and the limitations of the standard testing protocol.  
 
Industry scientists were not only aware of behavioural compensation, but developed 
strategies to facilitate and reward it.55,56,57  As Colin Grieg explained in a presentation to 
his BAT colleagues, the objective was, “…to produce a cigarette which can be machine 
smoked at a certain tar band, but which, in human hands, can exceed this tar banding."29   
This product strategy was articulated in more detail at an international conference of 
BAT researchers and marketers the following year: “The challenge would be to reduce 
the mainstream nicotine determined by standard smoking machine measurement while 
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increasing the amount that would actually be absorbed by the smoker.”58  G. Brookes, 
another senior researcher speaking at the same conference, noted: “we should strive to 
achieve this effect without appearing to have a cigarette that cheats the league table [of 
ISO tar yields]. Ideally it should appear to be no different from a normal cigarette…It 
should also be capable of delivering up to 100% more than its machine delivery.”59   
 
This strategy spawned a new design concept whereby cigarettes would provide greater 
“reward” to smokers for a given puff volume: "Whatever the outcome of the various 
public debates on compensation and test procedures, we must aim to use our knowledge 
to develop products that respond to human smoker needs. The concept of 'smoke 
elasticity' can be expected to play an important role.”60  Elasticity refers to a phenomenon 
where the concentration of tar and nicotine in cigarette smoke increases as puff volume 
increases.61  In other words, elastic cigarettes not only facilitate more intensive puffing in 
human hands, but also produce greater concentrations of tar and nicotine for a fixed 
volume of smoke at puffing levels typical of human smokers, relative to the standard ISO 
machine puffing regime. For example, a 50% increase in smoke volume above the ISO 
puffing regime might produce a 65% increase in nicotine yield. 
 
The practice of designing ostensibly “low-yield” brands that actually delivered more tar 
and nicotine to smokers raised ethical concerns among some of the industry’s senior 
scientists.  For example, in 1984, David Creighton from BAT questioned the way elastic 
cigarettes were being marketed: “Is this an ethical thing to do? People who buy an 8 mg 
product expect to get 8 mg. … If a declaration that this product is elastic is made (which 
is the honest thing to do) then it could upset the apple cart.” 62  Not wanting to upset the 
apple cart, the industry decided to keep elastic cigarettes secret, and—whatever design 
changes were introduced to increase elasticity— it was agreed that they should be subtle: 
"The consensus is that small improvements in elasticity which are less obvious, visually 
or otherwise is likely to be an acceptable route."17  Furthermore, “large changes in 
delivery are not credible (i.e. 1 mg machine delivery giving 10 mg through the consumer 
compensation). Better to have a 9 mg product giving 15 mg.” 17  
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Despite the ethical concerns of its scientists and the health risks to consumers, elastic 
cigarette design soon became an important part of the industry’s overall product strategy. 
In a presentation entitled BAT stance on compensation, C.I. Ayres communicated this 
policy to an international audience of industry researchers and executives: “From a 
research and product development viewpoint the proposition of designing a cigarette, of 
high taste to tar ratio, which responds positively to human smoking behaviour has been 
agreed to be acceptable.”17  In other words, tobacco manufacturers intentionally designed 
a class of cigarettes which delivered significantly more toxicants to smokers than the 
numbers on their packs and advertisements indicated, and kept this product strategy 
secret from consumers and regulators.  
 
 
1.7 Standard Deliveries and Brand Rankings 
 
Although the tobacco industry has acknowledged some of the limitations of the ISO 
machine testing protocol, they continue to argue that “Mainstream smoke yields 
determined by the standard smoking methods are appropriate for the ranking of cigarettes 
with respect to their yield.” 63  In other words, the tar and nicotine values printed on 
cigarette packs and reported to regulators can be used to compare brands, even if they 
aren’t precise enough to predict the nicotine and tar delivered to individual smokers. 
 
However, elastic cigarette brands have important implications for so-called brand 
rankings. More “compensatible” and elastic brands that provide relatively low yields 
under the ISO machine testing may “leapfrog” non-elastic brands when smoked by 
humans. Table 1 provides an example drawn from BAT research.64 Table 1 indicates 
brand with the lowest tar yields under the ISO machine protocols actually delivers the 
most tar to smokers. Senior BAT scientists remarked upon this phenomenon and 
concluded that the ISO brand rankings can, “mislead individual smokers. In particular, 
small differences in simple tables are meaningless and suggestions that single indices 
covering several factors have any scientific foundation at present must be totally 
rejected." 65   
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Players Filter Regular 25.3 1 17.0 2 
DuMaurier King Size 23.2 2 16.7 3 
Matinée King Size 13.6 3 20.7 1 
     
 
 
The example in Table 1 demonstrates that even large differences in ISO machine yields 
can be meaningless when brands are smoked by humans—in fact, the ISO tar rankings 
are completely reversed when the brands are smoked by humans. R.S. Wade, a senior 
BAT researcher, came to the same conclusion: "The ITG report on ‘Project Jigsaw’ was 
indeed extremely interesting particularly in pointing out the irrelevance of tar levels to 
smokers...”19  One of BAT’s leading researchers, David Creighton, agreed: “It is 
impractical to use…standard machine smoked deliveries to predict the deliveries or the 
ratios of the deliveries of cigarettes smoke components.”43  In other words, consumers 
who use the standard tar numbers to choose a “lower tar” and presumably less harmful 
brand—as many do— are being deceived. 
 
 
1.8 Cigarette Yields and Marketing Strategy 
 
In public, the tobacco industry has insisted that the ISO testing protocol is “not meant to 
predict actual smoker intake.” 66 In other words, the ISO method is only designed to rank 
machine yields and not the “delivery” of constituents to smokers.67 The flaws, therefore, 
lie not with the testing method, but how smokers have been interpreting its results.  
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In practice, however, the tobacco industry has carefully cultivated the misperception that 
the machine yields that appear on packages are, in fact, measures of actual human 
delivery and indicative of a safer product.  Beginning in the 1960’s, tobacco 
manufacturers began to promote the ISO tar yields of brands directly to consumers, even 
though these tar yields bore little or no relation to the levels consumers could expect (see 
Figure 4). Tobacco manufacturers also used “light” and “mild” brand descriptors and 
brand imagery to promote “low-tar” brands as healthier alternatives.68 This duplicity is 
captured in documents from BAT: “Low tar [brands] that smoke like middle tar is most 
appropriate for middle tar smokers switching down due to concern of ‘health’.”  In 
hindsight, “low-tar” cigarettes represented more of a marketing strategy than a product 
revolution, and there is ample evidence to suggest that this marketing strategy has 
succeeded. To date, a majority of smokers continue to believe that “low-tar” cigarettes 
are healthier, an erroneous belief that may reduce the likelihood of quitting among a 
substantial proportion of smokers.69,70 
 
Figure 4. Examples of “low-tar” advertising 
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1.9 Policy Implications 
 
At present, the regulatory mechanism for testing cigarette toxicity provides constituent 
information that is at best misleading and, in many cases, deceptive. Highly elastic 
cigarettes, when tested under the standard protocols with unrealistically low puffing 
regimes, also have the potential to subvert progressive policies intended to reduce 
cigarette toxicity. For example, the European Union (EU) recently introduced its “10-1-
10” directive, in which all brands must not surpass 10mg of tar, 1mg of nicotine, or 
10ppm of carbon monoxide.71  Because the EU directive uses the ISO machine method as 
its testing standard, all brands give the appearance of meeting these regulatory standards, 
but actually deliver levels of tar and nicotine that are far higher than the 10-1-10 limits. 
 
Any policy that seeks to limit smoke constituents will be meaningless unless it is based 
upon valid testing protocols that are relevant to human smokers. There are growing calls 
for change in the testing standards among independent research and even from within the 
FTC itself. 72,73  In response, the World Health Organization (WHO) is currently holding 
discussions with scientists, regulatory agencies, and the International Standards 
Organization with the aim of revising the ISO testing protocols.  
 
There is growing support either to supplement or replace the existing ISO standard with a 
more intensive smoking regime. In fact, the Canadian and Massachusetts governments 
have already mandated more intensive testing protocols (see Table 2).  
 
The extent to which these alternative protocols succeed where the ISO protocol fails is 
unclear. The tobacco industry has recently argued that these more intensive protocols will 
overestimate smoke intake and, therefore, should not be adopted more widely.74 In 
particular, they have argued that the 100% vent-blocking condition in the ISO 
Intense/Canadian protocol is rarely seen among human smokers and will therefore 
generate unrealistically high yields. In contrast, internal industry documents suggest that, 
in many cases, human smoking behaviour may actually exceed the parameters used in the 
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ISO Intense/Canadian and Massachusetts protocols. There is, however, no consensus 
outside of the industry as to the validity of these alternative protocols. 
 




















       
FTC 0 35 60 2.0 17.5 Filter + 8mm 
ISO 0 35 60 2.0 17.5 Tipping+3mm 
or 23mm 
Massachusetts 50% 45 30 2.0 22.5 Tipping+3mm 
or 23mm 
Canadian  100% 55 30 2.0 27.5 Tipping+3mm or 23mm 
       
 
 
The principal obstacle to developing and evaluating alternative testing regimes remains 
the lack of data on human puffing behaviour. 75 As a BAT researcher noted in 1984, 
“Governments and their associated laboratories are aware of compensation but are 
reluctant to change since they can offer no viable alternative to the present smoking 
regime.”76 Also, “the high and low end points of ‘likely’ intake of ‘most smokers’ for 
each of the hundreds of cigarette brand styles on the market have not been established,” 
largely due to the difficulties of measuring smoking behaviour outside of the laboratory 
setting.67  In other words, even the basic parameters of human puffing behaviour that 
could serve as valid benchmarks for testing protocols are lacking. 
 
The lack of data is, in part, due to the challenges inherent in measuring puffing 
behaviour. Laboratory studies have typically required participants to smoke one or two 
cigarettes through a mouthpiece attached to a desktop machine.16  There are inherent 
limitations to this design. Even in ad libitum trials, where participants are asked to smoke 
as they normally do, smoking topography has been shown to change based upon the 
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number and timing of cigarettes smoked, as well as reactivity to the topography 
machine.77 78 79 Although biochemical values from conventional and “machine” smoking 
in a laboratory environment appear to be similar, this does not imply that laboratory 
smoking is the same as conventional smoking in a naturalistic setting. Considering that 
the total time spent puffing on a cigarette is, on average, less than 20 seconds, even small 
deviations from normal cigarette smoking behaviour can have a substantial impact upon 
estimates of smoke intake.16  Indeed, one of the first published studies of smoking 
behaviour that helped to shape the protocols for the FTC method over 60 years ago noted 
that subjects “under examination” are apt to be nervous and smoke somewhat more 
vigorously than normal.80 The few studies that have measured smoking topography 
outside of the laboratory also suggest that conventional puffing behaviour may well differ 
from measures observed in the laboratory.81,82 Unfortunately, studies outside of the 
laboratory have rarely been able to measure puff volumes, the critical measure necessary 
to calculate total smoke intake.78,81,83,84 In addition, with few exceptions,85 measurements 
of smoking topography have been limited to 1 or 2 cigarettes. As a result, the studies that 
have estimated the effects of brand switching on puffing behaviour have had to rely on 
transient reactions to brand switching, which may not relate well to longer-term changes 
in smoking topography. In summary, current estimates of smoking topography lack an 
important degree of external validity; indeed, knowledge of in vivo smoking topography 





The issue of how to test and ultimately regulate tobacco products represents a critical 
challenge for the public health community. Although the current international testing 
regime for cigarettes is widely acknowledged to be seriously flawed, there is a lack of 
data to guide potential alternatives. There is a particular need for non-industry research 
on naturalistic puffing behaviour that can serve as a benchmark to evaluate existing 
testing protocols and to develop a replacement for the ISO standard. There is also a need 
 19
to examine how smoke constituents change in response to different smoking conditions 
and brand designs. This interaction between the smoker and the cigarette is critical to our 
understanding of the toxicity of tobacco products. 
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2.0 RESEARCH OBJECTIVES 
 
The current study sought to address the following questions:  
 
1. What are the normal puffing parameters of human smoking behaviour, and to what 
extent does puffing behaviour differ between individuals? 
 
2. How does puffing behaviour and nicotine uptake change following a switch to a “low-
yield” cigarette brand?  
 
3. To what extent does puffing behaviour predict nicotine uptake? 
 
4. Are the puffing regimes used by machine testing regimes representative of mean 
human puffing behaviour? 
 
5. To what extent do cigarette yields change across different machine testing regimes? 
 
6. How do cigarette yields determined under “standard” machine testing regimes (e.g., 
the ISO regime) relate to machine-yields generated from human smoking behaviour?   
 
7. To what extent is self-reported puffing behaviour associated with demographic 
variables and key measures of smoking behaviour?  
 
8. To what extent are changes in cigarette brands associated with self-report puffing 
behaviour? 
 
These research questions were examined through two related studies: 1) a field study of 
smoking behaviour, and 2) the International Tobacco Control Policy Evaluation Survey 
(ITCPES), a cohort survey of over 2,000 adult smokers randomly selected in each of four 
countries—Canada, United States, United Kingdom, and Australia—which included self-
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report measures of smoking behaviour derived from the field study.  The following 





3.1 Field Study of Smoking Behaviour 
 
3.1.1 Participants 
Participants were recruited through a random-digit dial (RDD) telephone survey 
conducted between March and April 2003 in the Waterloo Region (See Appendix A). 
Respondents who smoked a minimum of 5 cigarettes per day, had no intention to quit 
smoking in the next 3 months (the duration of the study period), and who smoked brands 
with ISO tar yields between 10 and 14mg were invited to take part in a “field” study on 
smoking behaviour. A list of eligible brands was created from brand data provided by 
Health Canada.  
 
3.1.2 Procedures 
At the conclusion of the telephone survey, eligible respondents were asked to take part in 
a field study of smoking behaviour. Eligible respondents who expressed interest in the 
study were re-contacted approximately one-week later to confirm eligibility and to make 
an appointment for the first visit (see Recruitment Script in Appendix B). Participants 
were given the option of visiting the laboratory in the Department of Psychology at the 
University of Waterloo, or arranging for a home visit. All visits were conducted by a 
team of two trained research assistants.  
 
The field study consisted of 3 one-week trials. For each trial, participants smoked at least 
5 cigarettes a day through the smoking topography device for 5 consecutive days, 
between Monday and Friday. For Trial 1, participants smoked their usual brand of 
cigarettes. Approximately 6-weeks later, participants completed a second 5-day trial 
(Trial 2), smoking their usual cigarette brand through the device, as before. Trial 3  
occurred during the week immediately following Trial 2. For Trial 3, half of the 
participants (n=24) were randomly selected to smoke a “lower-yield” cigarette brand 
(Matinee Extra Mild, 4mg tar/0.8mg nicotine ISO yield), whereas half continued to 
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smoke their usual brand (n=27). These lower-yield cigarettes were matched for length 
and diameter with the participant’s usual cigarette brand. All participants were provided 
with cigarettes for Trial 3 –either their regular brand or the lower-yield brand— free of 
charge. Table 3 provides an outline of the study protocol.  
 
Table 3. Overview of study protocol 
Week Description 
  
1 Baseline Phone Survey 
2 Recruitment 
3 Trial 1 
8 Follow-up Phone Survey 
9 Booking 
10 Trial 2 
11 Trial 3 
 
 
Prior to each trial, participants were provided with an overview of how to use the 
smoking topography device. Participants were instructed to use the device whenever they 
smoked a cigarette. Participants were also asked to model how they normally held their 
cigarette. The Research Assistant then demonstrated how to use the device using a similar 
grip on their cigarette.   
 
Participants completed daily diaries to record their daily consumption and any difficulty 
with using the devices (see Appendix C). Following each trial, participants responded to 
a 5-minute “post-use” questionnaire, and provided a saliva sample. Saliva samples were 
collected using Salivette™ containers according to a standardized protocol and frozen 
immediately after collection. This study received ethics clearance from the University of 








A 20-minute random digit-dial (RDD) telephone survey was conducted within the 
Waterloo Region. This survey included standardized measures of smoking behaviour, 
demographic variables, and key psychosocial variables, such as intentions to quit (see 
Appendix A). The survey also included seven questions on puffing behaviour (see Table 
4). Given that we were unable to identify any pre-existing self-report measures of puffing 
behaviour, these questions were created specifically for the current study. The survey 
included questions that were intended to mimic each of the individual puffing parameters 
of smoking behaviour (e.g., puff number). Given the exploratory nature of these items, in 
some cases, multiple self-report measures were intended to assess the same puffing 
parameter.  
 
Table 4. Self-report measures of puffing behaviour  
Butt length 
 
When you smoke, how much of the cigarette do you usually smoke? READ 
01 – About half of the cigarette or less   
02 – Most of the cigarette  
03 – Nearly to the butt 





Which of the following best describes how strongly you usually inhale when you 
smoke? READ 
01 – You just puff, you don’t really inhale   
02 – You inhale well back into your mouth  
03 – You inhale as far back as your throat 
04 – You inhale only partly into your chest 






Which of the following statements best describes how many puffs you usually take 
when you smoke a cigarette? READ 
01 – You only take a few puffs on each cigarette 
02 – You take more than a few puffs, but not as many as you could 











When you smoke, how deeply do you inhale? READ 
01 – Not at all deeply 
02 – Somewhat deeply 
03 – Very deeply 





On average, how long do you let the cigarette burn in between puffs?  






After you light a cigarette, how often do you usually put your cigarette down or hold 
it away from your mouth when you smoke?  
01 – Never 
02 – Not at all often 
03 – Often 




Smoking Topography Device 
The CReSSmicro device (Plowshare Technologies, Inc.; Baltimore, Maryland) is a 
battery-operated portable device that measures the full complement of puffing parameters 
(puff volume, puff number, puff duration, average flow, inter-puff interval, time, and 
date). The device is small (2.5” x 2.2” x 1.2”, 3.1oz), allowing for independent use in the 
participant's natural environment. The CReSSmicro uses an orifice flow meter 
mouthpiece that produces a pressure drop related to the flow rate of smoke through the 
mouthpiece. This pressure drop is measured in real-time by the CReSSmicro device using 
an onboard pressure transducer and is converted into the corresponding flow rate. All of 
the puffing variables are derived from the basic measurements of flow and time.  
 




On the day before each one-week smoking trial, each CReSSmicro device was calibrated 
at “low,” “medium,” and “intense” puffing conditions (see Appendix D). Each device 
was also tested under the same puffing conditions immediately following pick-up of the 
devices, in order to ensure the accuracy of the device during the study period. Any 
changes in sensitivity between pre- and post-use testing were noted. Data were 
downloaded from the device immediately following each one-week trial.  
 
Cotinine Samples 
Cotinine is the major metabolite of nicotine with a half-life of approximately 18-hours, 
and is a reliable indicator of nicotine uptake.86,87  In addition, there is good 
correspondence between salivary measures of cotinine and both urinary and serum 
cotinine levels.88  Immediately following each smoking trial, participants were asked to 
provide a saliva sample, which was then frozen for storage. The saliva samples were 
analysed for cotinine by Labstat International Inc. (Kitchener, Ontario) using a rapid gas-
liquid chromatographic method.89  
 
Brand Elasticity 
Elasticity refers to brands that deliver greater tar and nicotine under more intense puffing 
than would be expected from the “standard” tar and nicotine yields determined under ISO 
testing conditions. We calculated a measure of elasticity for each of the brands included 
in the field study using testing data obtained from Health Canada. This measure was 
included in our analyses to examine whether brand elasticity would help to account for 
any discrepancy between the listed ISO nicotine yield of a brand and nicotine uptake 
among the participants, measured through salivary cotinine.  
 
Brand elasticity was calculated using the Brown and Williamson formula90, which tests 
the increase in nicotine delivery relative to increases in puff volume, as follows:  
Elasticity= (D56mL /P56mL) x (P44mL /D44mL) x (V44mL /V56mL) 
Where D = nicotine delivery, P=the number of puffs, and V=puff volume for cigarettes 
smoked at 44mL and 56mL puffing regimes. Values greater than 1 indicate an “elastic” 
brand, with proportionally greater increases in delivery than puff volume. Elasticity 
 27
values for the current study were drawn from tests conducted by Labstat International 
Inc. in 1997 on behalf of Health Canada.  Twenty replicates* of 115 Canadian brands 
were tested through a Filtrona smoking machine at 44mL and 56mL puff volumes under 
otherwise normal ISO smoking conditions (i.e., 2-second puffs, once per minute, with 
unobstructed vent holes). The number of puffs, nicotine, tar, and CO yields were 
determined under the 44mL and 56mL puffing regimes for each brand.  
 
Daily Diary 
Participants recorded the time of their first cigarette of the day and the total number of 
cigarettes smoked, including both cigarettes smoked using the CReSSmicro device and 
those smoked without the device. The daily diary was also used to record any problems 
with the device or the study protocol (see Appendix E).  
 
 





Samples of each of the 21 cigarette brands smoked by participants in the field study were 
purchased and sent to Arista Laboratories (Richmond, VA) to test the tar, nicotine, and 
carbon monoxide yields. Two replicates (5 cigarettes per replicate) of each brand were 
smoked through a Filtrona smoking machine according to each of five protocols: the ISO, 
Canadian, Massachusetts, Compensatory, and Human Mimic protocols (see below for a 
description of each). The same standard methodology was used to measure the nicotine, 
tar, and carbon monoxide yields for each protocol.12  Briefly, particulate matter from the 
mainstream smoke was collected on a 44-mm Cambridge filter pad from each smoking 
port, which was then removed and weighed to measure total particulate matter. Extract 
from the filter pad was injected into a gas chromatograph to determine the moisture 
content and nicotine yield. Gases that passed through the filter pad were collected and 
                                            
* A replicate refers to each “set” of five cigarettes tested at the same time through the 
Filtrona machine.  
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then tested to determine carbon monoxide levels.91  Tar level was determined by 
subtracting the water and nicotine levels from the total particulate matter. 92,93   Puff 
count was recorded to the first decimal point.  
 
3.2.2 Testing Protocols 
 
A full discussion of the ISO protocol is provided in the Introduction. The Canadian 
(CAN) and the Massachusetts (MASS) protocols are variants of the standard ISO testing 
regime; both increase the frequency and size of puff volumes relative to the ISO regime, 
and both block a percentage of filter vent-holes prior to testing. The main difference 
between the two is the increase in puff volume (CAN=55ml/puff, MASS=45ml/puf) and 
the proportion of vent-hole blockage (CAN=100%, MASS=50%). 
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0 35 60 2.0 17.5 Tipping + 3mm 
Massachusetts 50% 45 30 2.0 22.5 Tipping + 3mm 
Canadian 100% 55 30 2.0 27.5 Tipping + 3mm 
Compensatory* 50% Variable Variable 2.0 Variable Tipping + 3mm 
Human Mimic* 50% Variable Variable Variable Variable Tipping + 3mm 
       
* Note that the puffing parameters from the Compensatory and Human Mimic 
protocols varies across cigarette brands. 
 
Compensatory Protocol 
This protocol has been proposed by Kozlowski and O’Connor in an effort to incorporate 
behavioural compensation into the testing regime.73  They advocate varying the puff 
volume and frequency according to the nicotine yield determined in the ISO method. In 
other words, each brand is tested using the ISO method and the ISO nicotine yield is used 
to determine the puffing parameters for a second round of testing—the compensatory 
testing. Brands with high ISO nicotine yields are smoked less intensely, while brands 
with low ISO nicotine yields are smoked more intensely under this compensatory regime.  
Brands with 1mg of nicotine are tested using a 40mL puff taken every 60 seconds. With 
every 0.1mg decrease in ISO nicotine, the puff volume increases by 4ml and puff 
frequency decreases by 4 seconds. For example, a cigarette with .5mg of nicotine under 
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the ISO method would be smoked at 60ml puffs every 40 seconds under the 
Compensatory test, while a 0.1mg cigarette would be smoked at 76mL puffs every 24 
seconds.  In contrast, with every 0.1mg increase in nicotine above 1.0 mg, puff volume 
decreases by 4ml and puff frequency increases by 4 seconds. Table 6 illustrates the 
compensatory regime. Appendix F also provides the actual compensatory testing 
parameters for each brand included in the current study.  
 










   
0.7 52 48 
0.8 48 52 
0.9 44 56 
1.0 40 60 
1.1 36 64 
1.2 32 68 
1.3 28 72 
   
 
 
Human Mimic Protocol 
Human Mimic protocols use  puffing behaviour recorded from actual smokers to set the 
testing parameters for the Filtrona machine. In the current study, we used the puffing 
behaviour recorded from the subjects in the field study to determine the Human Mimic 
testing parameters for each brand. In cases where a particular brand was smoked by more 
than one subject, the average puffing level was used. The Filtrona smoking machine was 
then programmed to smoke cigarettes using these “mimic” puffing levels. The testing 
parameters for each brand are listed in Appendix G. Note that this type of testing protocol 
has been used extensively by tobacco manufacturers to test their products, as described in 





3.3 International Tobacco Control Policy Evaluation Survey 
 
The ITC Survey is an international cohort survey of adult smokers designed to evaluate 
the effectiveness of national-level tobacco control policies, including taxation and public 
smoking restrictions. One important aspect of the ITC survey is to examine the different 
ways in which smokers may respond to such policies. For example, although many 
smokers respond to an increase in cigarette taxation by purchasing fewer cigarettes and 
reducing their consumption, they may compensate for this reduction by smoking more of 
each cigarette, taking larger puffs, and inhaling the smoke more deeply. In this way, it is 
possible to increase the nicotine uptake per cigarette and maintain nicotine levels at a 
lower cost. Thus, before one can infer a public health benefit from policies that prompt 
reductions in daily consumption, compensatory behaviours, such as changes to puffing 
behaviour, need to be taken into account.  
 
One of the main objectives of the field study was to validate self-report measures of 
puffing behaviour that could be administered through the ITC survey. Three measures 
were introduced in Wave 2 of the ITC survey, conducted between June and August 2003. 





Participants in the ITC Survey were 18 years or older, had smoked more than 100 
cigarettes in their life, and smoked at least once in the past 30 days.  The cohort was 
constructed using probability sampling methods with telephone numbers selected at 
random from the population of each country, within strata defined by geographic region 
and community size. Eligible households were identified by asking a household 
informant the number of adult smokers living in the household. The Next Birthday 
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Method94 was used to select the respondent in households with more than one eligible 
adult smoker. Representative samples of adult smokers were recruited from each of four 
countries: Canada, the US, the UK, and Australia. Note that the ITC measures of puffing 
behaviour were only asked of current smokers. As a result, ITC respondents who reported 





The survey was conducted using Computer Assisted Telephone Interviewing (CATI) 
software and was completed in 2 calls: a 10-minute recruitment call was followed one-
week later by a 40-minute main phone survey. In order to increase recruitment rates95, 
participants were mailed compensation equivalent to $10 USD prior to completing the 
main survey. Interviews were conducted by two survey firms: Roy Morgan Research 
(Melbourne, Australia) surveyed Australian and UK respondents, and Environics 
Research Group (Toronto, Canada) surveyed Canadian and US respondents. All aspects 
of the interviewer training and calling protocol were standardized across the two survey 
firms and closely supervised by the ITC team. Wave 1 of the ITC survey was conducted 
between October-December 2002. Wave 2 was conducted approximately 8 months later, 
and Wave 3 was completed between June and September 2004. A full description of the 






The ITC survey was standardized across the four countries: respondents in each country 
were asked the same questions, with only minor variations for colloquial speech. A copy 
of the Wave 2 ITC survey is available (http://www.itcproject.org); the following section 
provides a description of the measures used in the current study.  
 
Demographics and Smoking Behaviour 
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The survey included validated measures of smoking behaviour and quit history. Intention 
to quit was assessed by asking: “Are you planning to quit in the next month, 6 months, 
beyond 6 months, or not at all?” Level of education consisted of three categories: high 
school diploma or lower; technical, trade school, community college, or some university; 
and university degree. Annual income was categorized into “under $30,000,” “$30,000-
59,999,”and “$60,000 and over” for the US, Canadian, and Australian samples. For the 
UK sample, we used the following categories:  “₤15,000 or under,” “₤15,001-30,000,” 
and “₤30,001 and over.” Ethnicity was measured using the relevant census question for 
each country and then analyzed as a dichotomous variable to allow for comparisons 
across countries (“white” vs. “non-white and mixed race”), except Australia. Language 
was used as a proxy for Australian ethnicity (“English-speaking”=White, “Non-English 
speaking”=Non-White), as is consistent with the Australian census.  
 
Measures of Puffing Behaviour 
The following three self-report questions from the field study of smoking behaviour were 
included in Wave 2 of the ITC study: 1) Puff strength (“Which of the following best 
describes how strongly you usually inhale when you smoke?”); 2) Puff number (“Which 
of the following statements best describes how many puffs you usually take when you 
smoke a cigarette?”; and 3) Butt length (“When you smoke, how much of the cigarette do 
you usually smoke?” The Puff strength question was re-administered during Wave 3 of 
the ITC survey, and a measure of Puff frequency (“On average, how long do you let the 
cigarette burn in between puffs?”) was added.  
 
The study protocol was cleared for ethics by research institutional review boards at each 
of the following institutions: the University of Waterloo (ORE #10556), Roswell Park 
Cancer Institute (US), the University of Strathclyde (UK), and the Cancer Council of 





4.1 Data Cleaning 
 
All of the physiological data collected through the CReSSmicro devices was checked 
prior to analysis. Several device malfunctions were detected. Most of these consisted of 
“catastrophic” malfunctions, where either the machine stopped working altogether or the 
data that was recorded was obviously erroneous. In order to ensure the accuracy of the 
remaining data, every data point was reviewed by 3 independent raters. Each rater 
identified invalid data due to device misuse, device inaccuracies, or generally unrealistic 
values. The 3 raters agreed on 90% of all data points; all other data points were dropped 
from the analyses to ensure conservative standards for data quality. 
 
4.2 Smoke Intake 
 
A measure of total smoke intake was generated by multiplying the puff number by the 
mean puff volume recorded through the CReSSmicro device. A measure of total smoke 
intake for the machine testing protocols (e.g., ISO) was also calculated. For each 
protocol, the puff volume (e.g., 35ml) was multiplied by the mean number of puffs taken 
by the machine when testing each brand. 
 
 
4.3 Puff Frequency 
 
In both the Field Study and ITC surveys, the Puff Frequency measure asked respondents 
about “how long they wait in between puffs.” Responses to this item were reverse coded, 
so that increasing scores correspond to increasing frequency of puffing. Also note that the 




4.4 ITC Data 
 
Weights were constructed for each of the national samples included in the ITC data. The 
data was weighted to reflect the appropriate age-sex prevalence estimates within 
geographical strata (e.g., provinces), as well as to account for non-response and the 
survey design. All point estimates (e.g., mean cigarettes per day) are derived from 
weighted data. For multivariate analyses, there were no significant differences between 




All analyses were conducted using SPSS (Version 13.0). For linear regression models, 
standardized betas are reported, as well as “part” (semi-partial) correlations. In linear 
regression, the squared part correlation is the proportion of “unique” variance in the 
dependent variable accounted for by a given independent variable. In other words, it 
removes any “overlapping” variance in the dependent variable that may be accounted for 














A total of 520 respondents completed the baseline telephone survey. Seventy-six out of 
the 91 participants who met the eligibility criteria participated in Trial 1. Twelve of the 
76 were excluded after Trial 1 for failing to keep appointments or for violating study 
protocol, such as smoking other cigarette brands. Data from five additional participants 
were excluded during data cleaning, leaving a final sample of 59 participants. Of these, 
52 participants had valid CReSSmicro data for at least two one-week trials, with an 
additional 7 participants providing data for one trial only.  
 
Of the 59 participants, 30 were male (51%). Participants reported a mean age of 37.1 
(SD=11.1), 81% had finished high school, and 38% had completed some form of post-
secondary education. Participants smoked an average of 19.3 (SD=8.0) cigarettes per day 
(CPD) and 81% had previously tried to quit smoking. Although no participant intended to 
quit within 3 months (as per inclusion criteria), 73% planned to quit at some point beyond 




5.1.2 Use of the Smoking Topography Device 
 
Participants smoked a total of 6,493 cigarettes through the CReSSmicro device. An 
average of 67 cigarettes per participant was smoked through the device during the first 
two trials (54% of all cigarettes smoked during this period), and an average of 40 
cigarettes through the device at Trial 3 (52% of all cigarettes smoked), with no 
differences between the control and brand-switching groups. Only 2% of participants 
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reported that the CReSSmicro device was “hard” to use, and only 35% reported that 
using the machine did not feel “natural.” Approximately 42% reported that using the 
device did not change their smoking behaviour “at all,” 50% reported it changed their 
smoking behaviour “a little,” and 8% said it changed their behaviour “a lot.”  These 
measures were unrelated to measures of puffing behaviour or experimental condition. 
 
 
5.1.3 Parameters of Human Smoking Behaviour 
 
The primary objective of this research was to characterize measures of puffing behaviour 
among smokers using their usual cigarette brand. Table 7 provides measures of puffing 
behaviour for Trials 1 and 2. As the correlations between Trials 1 and 2 indicate, puffing 
behaviour was relatively stable within participants, across the two trials separated by 6 
weeks. In other words, there were few if any “spontaneous” changes in smoking 
behaviour observed among participants over the course of the 6 weeks. 
 

































































5.1.4 Individual Differences in Puffing Behaviour 
 
Although puffing behaviour was consistent within smokers, there were large differences 
in puffing observed between smokers. To illustrate these differences, smokers were 
separated into quartiles based upon their total smoke intake. Smoke intake was 2.4 times 
greater for smokers in the highest (863.2 mL, SD=111.0) versus those in the lowest 
quartile (359.4 mL, SD=67.5; t=14.5 p<.001). In other words, some smokers were 
inhaling the same amount of smoke from a single cigarette as other smokers were 
inhaling from two or three cigarettes.  
 
This variability in intake was observed even with smokers of the same cigarette brands. 
Table 8 includes mean puffing parameters for smokers within each of the three most 
popular brands smoked in the study. There were no significant differences among brands 
along any of the individual puffing parameters. Also note that the variability in total 
smoke intake within each of the two most popular brands –Players Light and DuMaurier 
Light— was equal to the variability in smoke intake observed among all 59 participants, 
across all brands. In other words, the variability in puffing behaviour and smoke 
inhalation would appear to be driven as much by the individual characteristics of 
smokers, as by differences between cigarette brands. 
 































































Puffing behaviour also varied between men and women. Although females took one extra 
puff per cigarette on average, males took significantly larger puffs (57.8mL, SD=11.6) 
than females (47.3mL, SD=10.1; t=3.7, p<.001). As a consequence, smoke intake was 
71ml or 12% greater among males (638.3mL, SD=214.1) than females (567.6, SD=178.7; 
t=1.4, p= .18). No other demographic variables were associated with smoke intake; 
however, participants who smoked more cigarettes per day waited longer in between 
puffs (r = .26, p=.04), with a non-significant trend towards lower smoke intake per 








5.2.1 Brand Switching and Puffing Behaviour 
 
Trial 3 of the field study was designed to examine whether switching to a “low-nicotine” 
brand was associated with any compensatory changes in smoking behaviour. A total of 
27 participants were randomly selected to smoke the “low-yield” Matinee Extra Mild 
brand (4mg of nicotine) at Trial 3. Approximately 73% of these participants found it 
“very different” smoking another brand, and only one participant reported noticing no 
difference at all. As Figure 6 illustrates, smoke intake per cigarette was 40% greater 
among those who switched to the “low-yield” brand (779.2 ml, SD=331.0) versus those 
who smoked their usual “regular-yield” brand (553.2 ml, SD=240.5; t =-2.8, p=.007). The 
increase in smoke intake was mainly accomplished through higher puff volumes among 
“low-yield” smokers (58.3mL, SD=16.1), compared to “regular-yield” smokers (49.3mL, 
SD=11.5; t=2.32, p=.02). There were no significant changes in smoking topography 
measures over the course of the 5-day trial among smokers in either condition; however, 
brand switchers increased their cigarette consumption from Trial 2 to Trial 3, relative to 
participants in the usual brand condition (+1.4 vs. -1.2 CPD; t=2.4, p=.03). Overall, 
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participants who smoke Matinee Extra Mild increased both the number of cigarettes per 
day, as well as the intensity with which they smoked each cigarette.  
 





























5.2.2 Brand Switching and Nicotine Uptake 
 
Salivary cotinine serves as a biological measure of nicotine uptake. In the current study, 
cotinine was assessed to examine the extent to which nicotine uptake changed following 
a switch to a “lower” yield cigarette brand. Among usual-brand smoking, salivary 
cotinine levels were similar across the three one-week trials (Trial 1=297.4 ng/mL, 
SD=143.5;  Trial 2=319.4 ng/mL, SD=139.5;  and Trial 3=291.7 ng/mL, SD=138.1). At 
Trial 3, there was a non-significant trend towards lower cotinine levels among “low-
yield” switchers (258ng/mL, SD=146.5), relative to usual brand smokers (325ng/mL, 
SD=123.5; t=1.8, p=.08). Cotinine levels decreased 12% between Trial 2 to Trial 3 
among brand switchers (299.2 vs. 262.4ng/mL; t=1.7, p=.07), significantly less than 
would be predicted from the 64% decrease in ISO nicotine yields from smokers’ usual 
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brand smoked at T2 and the low-yield brand smoked at T3 (means=.95mg and .36mg, 
respectively). In other words, the change in nicotine yield did not translate into equivalent 
changes in nicotine uptake among participants. Figure 7 shows the change in cotinine 
levels over the course of the three trials. 
 























Usual Brand  "Low Yield" Switch at Trial 3
 
 
Note that, among usual-brand smokers, saliva samples were collected later in the day at 
Trial 2 (+2.7 hours, t=4.1, p<.001) and at Trial 3 (+1.9 hours, t=3.3, p=.003), compared to 
Trial 1. As a result, participants in the usual-brand condition may have smoked a greater 
number of cigarettes shortly before the saliva sample was collected at Trial 2 and 3 
versus Trial 1. This may account for the higher cotinine levels observed at Trials 2 and 3 
among usual-brand smokers.  
 
Overall, these findings indicate that smokers increased the intensity of their puffing 
behaviour following a switch to a “low” nicotine yield brand, such that no significant 
changes in nicotine uptake were observed.  
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5.3 Cigarette Testing Protocols  
 
The results from the previous section help to characterize puffing behaviour for both 
“regular” and “low-yield” smoking. The next section examines the correspondence 
between these “human” measures of puffing and the puffing parameters used to test 
cigarettes in each of the leading testing protocols.  
 
5.3.1 Cigarette Testing Protocols and Puffing Behaviour 
Each of the 21 brands smoked by participants was purchased and tested under five 
different testing regime: the ISO, Massachusetts, Canadian, Compensatory, and Human 
Mimic regime. The mean puff count was recorded for each of the testing regimes. The 
smoke intake for each brand was calculated by multiplying the puff count by the puff 
volume, and represents the total volume of smoke that was generated by the machine 
testing protocol and analysed for tar, nicotine, and carbon monoxide. The mean puffing 
parameters for each testing regime are presented in Table 9. Note that the last column 
Table 9 also ranks the total smoke intake of each testing regime with respect to the smoke 
intake observed among participants in the field study.  
 
As Table 9 indicates (see following page), there was wide variability in the total smoke 
intake between the testing regimes. In other words, the puffing parameters used by each 
machine-testing protocol generated much different volumes of smoke. Among “regular-
yield” brands, the Human Mimic regime generated the greatest smoke intake, which 
ranked in the 64th percentile of smoke intake among participants from the field study. 
Smoke intake generated under the Canadian and Massachusetts regimes ranked in the 
55th and 53rd percentiles of human smoking, respectively. The ISO and Compensation 
protocols generated substantially lower machine smoke intakes, ranking in the 6th and 7th 
percentiles of human smoking, respectively.  
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Table 9. Comparison of smoke intake and smoking topography between human smoking 























        
Regular Yield*        
ISO 8.5 (0.9) 
2.0 
( - ) 
60.0 
( - ) 
17.5 
( - ) 
35.0 






( - ) 
30.0 




( - ) 
618.3 
(74.0) 53% 
Canadian 11.2 (1.0) 
2.0 
( - ) 
30.0 




( - ) 
621.2 
(44.4) 55% 
Compensatory  8.6 (0.8) 
2.0 
( - ) 
66.0 
( - ) 
17.0 
( - ) 
34.9 
( - ) 
300.1 
(58.3) 7% 











        
Low Yield†        
ISO 7.8 ( - ) 
2.0 
( - ) 
60.0 
( - ) 
17.5 
( - ) 
35.0 
( - ) 
273.2 
( - ) 0% 
Massachusetts 12.9 
( - ) 
2.0 
( - ) 
30.0 
( - ) 
22.5 
( - ) 
45.0 
( - ) 
581.1 
( - ) 29% 
Canadian 9.5 ( - ) 
2.0 
( - ) 
30.0 
( - ) 
27.5 
( - ) 
55.0 
( - ) 
523.4 
( - ) 21% 
Compensatory  10.4 ( - ) 
2.0 
( - ) 
36.0 
( - ) 
32.0 
( - ) 
64.0 
( - ) 
662.4 
( - ) 42% 
Human Mimic 12.5 ( - ) 
1.5 
( - ) 
29.1 
( - ) 
38.7 
( - ) 
58.0 
( - ) 
725.0 
( - ) 50% 
 * “Regular Yield: Mean Tar = 11.8, Nicotine=1.1  †  “Low-Yield”: Tar = 4mg, Nicotine=0.4mg  
 
For the low-yield brand, the Human Mimic regime again produced the greatest machine 
smoke intake, ranking in the 50th percentile of human smokers. The Compensatory was 
next, ranking in the 42nd percentile, whereas the Massachusetts and Canadian regimes 
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ranked in the 29th and 21st percentiles, respectively. Meanwhile, the ISO regime produced 
a lower smoke intake than was recorded from any of the 59 smokers in the field study. In 
addition, every condition except the Human Mimic regime underestimated the flow rate 
observed among human smokers. In other words, the ISO, Massachusetts, Canadian, and 
Compensatory regimes achieved their smoke volumes with lower intensity puffing than 
was observed among human smokers.  
 
Figure 8 illustrates the differences in smoke intake across testing regimes. As Figure 8 
indicates, the Canadian regime produced an equal volume of smoke as the Massachusetts 
regime for “regular-yield” brands and a lesser volume of smoke for the “low-yield” 
brand, despite having more intense puffing parameters. This is due to a smaller number of 
puffs drawn under the Canadian regime, which reflects a higher burn rate when more 
intensive puffs are drawn on the cigarette.  
 







































The Figure 8 illustrates the large discrepancy in smoke intake between regular and low-
yield brands for the Compensatory regime. This discrepancy reflects the “compensatory” 
nature of the testing parameters, which are more intense for “lower-yield” brands. The 
figure also shows the discrepancy between the smoke intake recorded among smokers 
using the CReSSmicro device and the smoke intake produced by the Human Mimic 
regime. This discrepancy was the result of different puff counts between participants and 
the Filtrona machine while conducting the Human Mimic testing regime. (The Filtrona 
machine was programmed to use the puff frequency recorded from human smokers, and 
to continue drawing puffs until the cigarette butt reached 23mm in length—the ISO 
standard.) Overall, participants took an average of 11.6 puffs while smoking their usual 
brand, compared to 13.1 machine puffs. In the “low-yield” smoking condition, 
participants took 13.6 puffs, versus 12.5 machine puffs. As a consequence, the Human 
Mimic regime produced 17% more smoke volume than participants for “regular-yield” 
brands and 7% less smoke volume for “low-yield” brands.  These discrepancies should be 




5.3.2 Testing Protocols and Cigarette Yields  
 
The smoke generated by each protocol was analysed for levels of nicotine, tar, and 
carbon monoxide (CO). The primary objective of including the Human Mimic regime, 
was to generate cigarette yields that approximated the levels of nicotine, tar and CO to 
which participants in the field trial were exposed. These “Mimic” yields could then be 
used as a benchmark to evaluate the standard testing protocols. As the following sections 
demonstrate, cigarette yields can be examined in several ways, including their absolute 






Table 10 shows the tar, nicotine, and CO yields for regular and “low-yield” brands tested 
under each of the five regimes. As the Table 10 indicates, the Human Mimic regime 
generated twice the nicotine, and more than double the tar and CO as the ISO regime for 
“regular-yield” brands. Both the Massachusetts and Canadian regimes generated even 
greater levels of tar, nicotine, and CO as the Human Mimic regime, whereas the 
Compensatory regime generated similar yields as the ISO regime. 
 
 
Table 10. Differences in cigarette yields according to testing regime 
 ISO MASS CAN COMP MIMIC 
      
“Regular-Yield” Brands 
    









      









      









      
“Low-Yield” Brand† 
    
Nicotine mg .4 1.2 1.6 1.4 1.5 
      
Tar mg 4.9 12.5 22.9 13.7 16.6 
      
Carbon Monoxide 4.4 13.4 22.9 13.8 19.2 
      
† Note: no standard deviations are listed given that only one low-yield brand was 
tested in the current study. 
 
 
For the “low-yield” brand, the differences between the Mimic and the ISO regime were 
even more pronounced. The Mimic regime generated yields between three and four times 
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greater than the ISO regime. The Canadian regime generated slightly higher yields than 
the Mimic regime, whereas the Massachusetts regime generated relatively lower levels 
for the “low-yield” brand. The yields generated by the Compensatory regime were 
somewhat higher than the Massachusetts regime, though still less than the Mimic regime. 
Note that the Canadian regime generated greater constituent yields than either the 
Massachusetts or the Mimic regime, despite generating less smoke. In other words, 
although the machine “inhaled” less smoke under the Canadian regime, this smoke was 
more concentrated, due to the 100% vent-blocking condition. Figure 9 illustrates the 
differences in smoke yields across the different testing regimes.  
 
Figure 9. Nicotine, tar, and carbon monoxide (CO) yields under ISO, Canadian, 








Nicotine CO Tar Nicotine CO Tar







ISO MASS CAN COMP MIMIC
 
 *CO = ppm / cigarette 
 
The nicotine yields produced under the ISO regime were highly correlated with the 
Canadian (r =.75, p<.001), the Massachusetts (r = .88, p<.001), and the Compensatory 
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regime (r = -86, p<.001), but not with the Human Mimic nicotine yields (r = -.08, p> 
.10). The same pattern was observed for tar and CO yields.  
 
Concentration of Yields 
The “absolute” levels of nicotine, tar, and CO shown in Figure 9 were generated under 
different smoking conditions and measured from different volumes of cigarette smoke. 
Expressing the levels of smoke constituents as concentrations can account for some of 
these differences across testing protocols.  Table 11 shows the concentrations of tar, 
nicotine, and CO per litre of smoke.  
 
Table 11. Concentration of smoke constituents per Litre of smoke, by testing protocol 
 ISO MASS CAN COMP MIMIC 
      
“Regular-Yield” Brands     



























      
“Low-Yield” Brand     
Nicotine (mg/1000ml) 1.7 2.0 3.1 2.0 2.1 
Tar (mg/1000ml) 17.5 21.5 42.4 20.7 22.9 
CO (ppm/1000ml) 15.6 23.1 42.4 20.8 26.5 
      
 
 
Table 11 indicates that the concentrations of nicotine, tar, and CO are more similar across 
testing regimes than the absolute levels presented in Table 10. For “regular-yield” brands, 
the difference in concentrations between the ISO protocol and the other regimes is 
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generally around 10%. In fact, the “regular-yield” brands tested under the ISO regime 
produced concentrations that were almost identical to the concentrations generated under 
the Human Mimic protocol. The “low-yield” brand produced somewhat larger 
differences in concentrations across protocols. For example, the tar and CO 
concentrations under the Canadian protocol are more than twice the concentrations in the 
ISO protocol. These results suggest that the difference in absolute levels between 
protocols isn’t simply due to a greater or lesser amount of smoke generated by each 
protocol. Rather, the smoking conditions also affect the concentration of nicotine, tar, and 
CO in given unit of cigarette smoke.   
 
 
Ratio of Yields 
 
Ratios of cigarette yields indicate how nicotine, tar, and CO vary in relation to each other. 
Given that smoking behaviour is generally assumed to be driven by nicotine, nicotine 
ratios indicate the levels of tar and CO smokers can expect to receive when extracting 
their nicotine dose. For example, a brand with lower tar/nicotine may be more favourable 
from a public health perspective than a brand with higher tar/nicotine.  Table 12 (see 
following page) shows the mean ratio of tar/nicotine and CO/nicotine under each testing 
protocol. 
 
As Table 12 indicates, there were considerable differences in the nicotine ratios across 
testing protocols. Among brands tested by the Canadian protocol, the range of 
tar/nicotine ratios was between 11.8 and 14.4—a difference of approximately 20% in the 
amount of tar delivered for a fixed amount of nicotine. There was a general trend towards 
higher tar/nicotine ratios as the intensity of the smoking regimes increased from ISO, to 
Massachusetts, to Human Mimic, to the Canadian regime.  
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Table 12. Ratio of tar and carbon monoxide to nicotine, by testing protocol 
 ISO MASS CAN COMP MIMIC 
      
“Regular-Yield” Brands     












      
CO / Nicotine 











      
“Low-Yield” Brand     
Tar / Nicotine  10.2 10.5 13.8 10.1 10.9 
      
CO / Nicotine  9.1 11.3 13.8 10.9 12.6 
      
 
 
The tar/nicotine ratio for some brands may be more sensitive to different testing 
conditions than others. The ISO nicotine yield of a brand was strongly related to the 
change in tar and nicotine ratios. For example, lower ISO nicotine yields were associated 
with greater differences in the tar/nicotine ratios between the ISO and Canadian regime (r 
= -.66, p =.004) regime. In other words, brands that generated low nicotine yields under 
the ISO protocol were more likely to deliver higher tar/nicotine ratios under more intense 
smoking conditions. 
 
Overall, these findings suggest that the testing protocols generate significantly different 
constituent profiles for the same brands, both in terms of the “raw” amounts of tar, 
nicotine, and CO, as well as the concentration and relative amounts of these constituents 
in cigarette smoke. In other words, the testing protocols provide much different 
characterizations of potential toxicity of cigarette brands. Compared to the yields 
generated under a testing regime that “mimicked” human smoking behaviour, the ISO 
protocol systematically underestimated human exposure levels for virtually every 
measure. 
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5.3.3 Cigarette Yields as a Predictor of Nicotine Uptake Among Smokers 
 
The most common use of cigarette yields is to predict levels of individual exposure 
associated with a particular brand. For constituents such as nicotine, biological measures 
of uptake are available to test the extent to which the machine-tested nicotine yields are 
associated with the levels of exposure (i.e. cotinine). In the current study, we examined 
the association between cotinine levels collected from participants in the field study and 
the machine-tested cigarette yields from each of the five testing regimes. We also 
examined whether the individual measures of puffing behaviour collected from 
respondents were associated with cotinine and interacted with the nicotine yields in any 
way.  
 
A linear regression model was run to examine predictors of cotinine. In Step 1, cigarettes 
per day (CPD), mean smoke intake, and the time of day the salivary cotinine sample was 
collected were entered into the model. All of the demographic variables were then 
entered. Only one variable—gender—was significant and remained in the model, 
whereas age, height, weight, and ethnicity were dropped from subsequent steps. 
Appendix H presents results the final model from Step 1.  
 
In the second step of the model, two-way interaction variables were added. The 
interaction between CPD and smoke-intake was significantly associated with cotinine, 
and resulted in a significant increase in the total variance accounted for by the model (R2 
change=.21, p =.001). This relationship was consistent across trials for usual brand 
smoking, as well as for “low-yield” smoking at Trial 3. The results for Step 2 are 
presented in Appendix H. 
 
In the third step, machine generated nicotine yields were entered into the model. (Note 
that a separate model was run for each of the testing protocols; results for each of the 
models are presented in Appendix H.)  A summary of the results from these models is 
provided in Table 13. As the table indicates, only the Human Mimic yields were 
significantly associated with salivary cotinine levels, and that even human mimic yields 
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were only modestly associated with cotinine. In other words, the nicotine yields of the 
ISO, Massachusetts, Canadian, and Compensatory models were not associated with 
nicotine uptake among participants, after adjusting for puffing behaviour and 
demographic variables. Also note that none of the machine generated yields were 
significantly associated with cotinine in bivariate analyses.  
 
Table 13. Association between nicotine yield (mg) and saliva cotinine at Wave 1† 




      
ISO .25 1.90 .07 .24 .47 
Massachusetts .11 .78 .44 .10 .40 
Canadian .17 1.21 .23 .16 .45 
Compensatory -.23 1.6 .12 -.21 .44 
Human Mimic .37 2.5 .02 .31 .51 
      
* Standardized beta 
† Yields were entered into separate models and all values are adjusted for gender, 
time of cotinine sample, CPD, mean inhalation volume, and CPD x smoke intake.  
 
A model incorporating the “intake-elasticity” variable was also run. Note that because the 
intake-elasticity variable incorporates both smoke intake and nicotine yield, it was treated 
as an interaction variable and entered into the model on the second step. The results 
indicate that the intake-elasticity variable was strongly associated with cotinine (β=.05, 
Partial r = .59), although the model with the intake-elasticity variable accounted for less 
variance in cotinine than the more parsimonious model incorporating the CPD x smoke 
intake interaction (R2=.41 versus R2=.51). In other words, there was no advantage to 
using the intake-elasticity variable.  
 
Overall, the results indicate that the machine-tested cigarette yields bear little association 
with measures of nicotine uptake among participants. Indeed, even the Mimic yields that 
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were derived from actual measures of human puffing behaviour were only moderately 
associated with individual levels of nicotine uptake.  
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5.4. Self-Report Puffing Behaviour 
  
As the previous section indicates, physiological puffing behaviours are an important 
predictor of nicotine uptake and general exposure. The following section examines the 
extent to which smokers can accurately report these physiological measures of puffing. 
More specifically, the following section: 1) Characterizes responses to these self-report 
measures, 2) Show the relation between self-report measures at different timepoints, 3) 
Examines the association between self-report measures and CReSSmicro measures of 
puffing behaviour, and 4) Examines their association with nicotine uptake. In order to 
distinguish between self-report measures and their corresponding CReSSmicro measure, 
all self-report variables have been capitalized in the following section. In other words, 
“Puff Number” refers to the self-report measure administered in the surveys, whereas 
“puff count” refers to the actual number of puffs recorded by the CReSSmicro device 
during the one-week smoking trials. 
 
 
5.4.1 Self-Report Versus CReSSmicro Measures of Puffing Behaviour 
 
Participants in the field study were administered self-report measures on four separate 
occasions: during the initial recruitment telephone survey and immediately following 
each of the three one-week CReSSmicro trials. Table 14 (see following page) provides 























     
Puff Number Scale (%)     
Only a few puffs on each cigarette 3.5 3.4 0.0 2.1 
More than a few puffs, but not as 
many as you could 49.1 47.5 57.6 52.1 
As many puffs as you can 47.4 49.2 33.9 45.8 
     
Puff Depth (%)     
Not at all deeply 5.2 5.1 0.0 2.0 
Somewhat deeply 65.5 62.7 70.4 59.2 
Very deeply 22.4 25.4 16.7 20.4 
As deeply as possibly 6.9 6.8 13.0 18.4 
     
Puff Strength (%)     
You just puff, you don’t really 
inhale  1.8 3.4 0.0 6.3 
Inhale well back into your mouth  3.5 3.4 7.4 14.6 
As far back as your throat 14.0 11.9 7.4 52.1 
Only partly into your chest 54.4 52.5 57.4 27.1 
As deeply into chest as possible 26.3 28.8 27.8 6.3 
     
Put Cigarette Down (%)     
Never 10.3 5.1 7.4 12.2 
Not at all often 13.8 23.7 31.5 20.4 
Often 56.9 59.3 44.4 55.1 




















     
Butt length (%)     
Half of the cigarette or less  6.8 0.0 1.9 0.0 
Most of the cigarette  
 35.6 35.6 24.1 22.9 
Nearly to the butt 49.2 47.5 61.1 64.6 
Right to the butt 8.5 16.9 13.0 12.5 
     
Puff Number (mean/SD) 
On average, how many puffs do you 









     
Puff Frequency (mean/SD) 
On average, how long do you let the 













As Table 14 indicates, few respondents endorsed the “least intense” options for puff 
depth, strength, the puff number scale, or butt length. In addition, there was considerable 
variability in the number of puffs reported by participants, as well as the average 
frequency of puffs.  
 
The post-trial measures may differ with the phone measures for two reasons: first, 
because of the different mode of administration (face-to-face vs. phone survey); and 
second, because participants have already answered the questions at least once, and 
recently completed the one-week trial with the CReSSmicro device. Table 15 examines 
potential differences between these two measures and their relation with the 
physiological puffing measures at Trial 1. (See Appendix I for the complete correlation 
matrix).  
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Table 15. Correlation between individual CReSSmicro and self-report measures of 
puffing at Trial 1 





    
Puff Number (scale) Puff count -.06 .07 
 Total intake -.02 .08 
    
Puff Number (open) Puff count .20 .30 
 Total intake .12 .05 
    
Puff Depth Puff volume  -.01 .22 
 Mean flow rate .09 .26 
 Total intake .20           .30* 
    
Inhale Strength Puff volume  .07 .07 
 Mean flow rate -.11 -.13 
 Total intake .11 .10 
    
Puff Frequency Puff frequency .61**   .72** 
 Total intake  .47**         .48* 
    
Put Cigarette Down Puff frequency           .27* .30 
 Total intake .25           .33* 
    
Butt length Puff Number .02 -.18 
 Total intake .05 -.05 
    
*p< .05 **p<.01  
 
As Table 15 indicates, the correlations varied considerably across puffing behaviours. For 
example, the Puff Number “scale” was virtually uncorrelated to puff count, whereas the 
“open-ended” Puff Number item was moderately correlated with puff count for both the 
pre and post-trial surveys. In some cases, the correlations between self-report and 
physiological measures of puffing differed between the pre and post-trial surveys. For 
example, the Puff Depth measure was uncorrelated to either puff volume or flow rate in 
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the pre-trial survey, in contrast to the moderate correlations observed for the post-trial 
Puff Depth measure. Overall, there appears to be a trend towards increasing correlations 
from the pre to post-trial surveys. The self-report measure with the highest correlations 
was the measure of Puff Frequency. Both the pre-trial and post-trial versions of this item 
were strongly correlated with both puff frequency and smoke intake, as measured by the 
CReSSmicro. 
 
A linear regression was conducted to examine which individual or combinations of self-
report measures were associated with CReSSmicro measures of total smoke intake. Self-
report measures with bivariate correlations greater than 0.10 were entered into a linear 
regression model predicting total smoke intake at Trial 1, adjusting for gender. 
Interaction variables were entered in the second step of the model. The results indicate 
that the most parsimonious model (R2 = .17, p=.02) included only gender and self-
reported Puff Frequency (β=1.9, p = .003, Part r =.47). Adding Puff Depth and a Puff 
Frequency x Puff Depth interaction variable (β=.65, p= .09, Part r =.26) provided a 
modest improvement in overall variance (R2 change=.15, p=.05). Note that the same 
model was significant when using measures from the post-trial survey, rather than the 
pre-trial telephone survey.  
 
Overall, these findings indicate a modest relationship between cross-sectional measures 




5.4.2 Changes in Self-Report Puffing Behaviour and Smoke Intake Across Trials 
 
One important consideration for self-report measures concerns their sensitivity to changes 
in puffing behaviour over time. For each self-report measure of puffing, a difference 
score was calculated by subtracting the value at Trial 3 by the value at Trial 2. 
Differences were also calculated for the physiological measures of puffing behaviour 
collected through the CReSSmicro at Trial 2 and 3. (Note that changes between Trials 2 
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and 3 were used because the brand-switching condition ensured a reasonable degree of 
change among physiological measures against which to validate the self-report 
measures.) 
 
Table 16 shows the “within-subject” correlations between changes in self-reported and 
physiological measures of puffing behaviour between Trials 2 and 3. As Table 16 
indicates, change in self-report Puff Number was significantly correlated with changes in 
puff count over the same period. Change in the self-report Puff Depth was also 
moderately correlated with changes in total smoke intake (r = .28, p=.08). A complete 
correlation matrix is provided in Appendix J. The same correlation matrix was generated 
after splitting the sample into the brand-switching and usual brand conditions. There were 
no significant differences in the patterns of results. Overall, it would appear that self-
report measures of puffing behaviour are somewhat less stable over time than the 
physiological measures collected through the CReSSmicro device, which exhibited 
strong correlations across trials, as indicated earlier in Table 7. 
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Table 16. Changes in self-report and physiological measures of puffing behaviour 
between Trial 2 and Trial 3 (n=51) 
Post-Use Survey CReSSmicro Measure Correlation 
   
Puff Number 
(scale) Puff count   .31* 
 Total Intake .24 
   
Puff Number 
(open) Puff count .02 
 Total Intake .01 
   
Puff Depth Puff volume .18 
 Mean flow rate .05 
 Total Intake .28 
   
Puff Strength Puff volume .07 
 Mean flow rate -.02 
 Total Intake .13 
Puff Frequency Puff frequency .16 
 Total Intake .15 
   
Put Cigarette 
Down Puff frequency .07 
 Total Intake -.01 
Butt length Puff count .04 
 Total Intake .04 
   
* p < .05 
 
A linear regression was conducted to examine whether combinations of self-report 
variables were related to changes in total smoke intake between Trials 2 and 3. Self-
report measures with bivariate correlations greater than 0.1 were entered into a linear 
regression model predicting total smoke intake, adjusting for gender. A model including 
only self-report Puff Depth (β=74.6, Part r =.32, p=.05) was the most parsimonious 
model (R2 =.13, p=.09). No other variables or interactions were significant. In other 
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words, puff depth was the only self-report puffing measure that was associated with 
physiological changes in smoke intake. 
 
We also examined whether self-report measures could discriminate between “usual-
brand” smokers and those who were switched to the “low-yield” brand in Trial 3.  Recall 
that participants who were switched to the “low-yield” brand for Trial 3 demonstrated 
significantly greater CReSSmicro measures of puff volume and total smoke intake 
relative to participants in the control condition, as noted in Section 5.1.7. We examined 
whether self-report puffing measures also differed between these groups. The results 
indicate that, compared to “usual brand” smokers at Trial 3, participants who switched to 
a low-yield brand reported smoking more of the cigarette (t=2.2, p=.03), reported taking 
more puffs per cigarette (t=1.9, p=.07), and reported puffing more deeply (t=2.9, p=.01). 
Overall, it would appear that the physiological changes in puffing intensity observed 




5.4.3 Self-Report Puff Behaviour as a Predictor of Nicotine Uptake  
 
Perhaps the most important test of self-report measures is the extent to which they are 
associated with biological measures of uptake. A linear regression was conducted to 
examine whether self-report puffing measures were associated with salivary cotinine 
levels at Trial 1. Self-report measures were selected from the pre-trial telephone survey 
given that these would provide the greatest generalizability to other population-based 
phone surveys. The first step of the regression model included the main-effect variables 
of gender, cigarettes per day, time of saliva sample, and Human Mimic nicotine yield—
the variables previously found to be associated with cotinine, as described in Section 
5.1.1. In the second step of the model, self-report measures of puffing that were 
correlated 0.1 or greater with cotinine were entered. Two-way interaction variables were 
entered in a third step.   
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Table 17. Self report cotinine predictors at Trial 1(n=51) 
 
  Beta* t p Part correlation 
     
Pick-up time  0.37 3.12 0.00 0.36 
Gender 
(Males=reference) 0.08 0.64 0.52 0.07 
CPD 0.07 0.57 0.57 0.07 
Nicotine Yield  
(Human mimic) 0.23 1.93 0.06 0.22 
Puff Depth (self-report) 0.27 2.17 0.04 0.25 
Butt length  (self-report) 0.27 2.27 0.03 0.26 
     
Puff Depth x Butt length 0.89 1.67 0.10 0.19 
     
  * Standardized Beta  Model R2= .26, p =.002 
 
 
As Table 17 indicates, the addition of two self-report variables, Puff Depth and Butt 
Length, accounted for a significant proportion of variance in cotinine (R2 change= .17 
p=.004) after adjusting for gender, CPD, time of saliva collection, and nicotine yield. A 
two-way interaction variable between Puff Depth and Butt Length was moderately 
associated with cotinine levels, although it failed to reach conventional levels of 
significance (Part r =.19, p=.10).  
 
 
5.4.4 Changes in Self-Report Puffing and Nicotine Uptake Across Trials 
 
A second linear regression model was conducted to examine whether changes in cotinine 
from Trial 2 to Trial 3 were associated with changes in self-report measures from the 
post-trial surveys. As Table 18 shows, changes in self-report measures of Puff Strength 
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and Puff Number (open-ended) were significantly associated with changes in cotinine 
over the same time interval. No interactions were significant. 
 
 
Table 18. Self-report predictors of cotinine change (n=44) 
  
  Beta* t value p value Part correlation 
     
Change in CPD 0.12 0.86 0.40 0.12 
Nicotine Yield 
(Human Mimic) 0.21 1.47 0.15 0.21 
Puff Strength change 
(self-report) -0.28 -1.94 0.06 -0.27 
Puff Number change 
(self-report) 0.26 1.87 0.07 0.26 
     
 






Overall, these findings provide some preliminary evidence that smokers are able to 
accurately report their puffing behaviour. In some cases, self-reported puffing was 
associated with measures of exposure, including changes in exposure over time. 
However, there were inconsistencies across models in terms of the individual self-report 
items that predicted smoke intake and salivary cotinine. 
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5.5. Self-Report Measures of Puffing in the ITC Survey 
 
The ITC survey provided an opportunity to examine self-report measures of puffing 
behaviour in population-based surveys. The following section provides a brief description 
of the ITC Sample, responses to the puff measures from the four nationally representative 
samples, as well as preliminary analyses of the relation between self-report puffing 





A total of 7,802 adult smokers responded to the Wave 2 of the ITC survey. 
Approximately 79% were recruited with the original cohort at Wave 1 (conducted 8-
months earlier), and the remaining 21% were recruited at Wave 2 to “replenish” the 
original cohort members lost to attrition. A total of 70% (n=5,408) of Wave 2 
respondents also completed the Wave 3 survey. Table 18 shows the sample sizes and 
Wave 3 follow-up rates for each country. Appendix Table 19 shows the sample 
characteristics of Wave 2 respondents by country. 
 
Table 19. ITC sample size at Wave 2 and 3.  
 CAN US UK AUS Total 
      
Wave 2 Respondents  2,004 1,896 1,928 1,976 7,802 
Wave 3 Respondents 1,430 1,072 1,312 1,431 5,245 
Follow-up Rate 71.3% 57.0% 68.0% 72.4% 67.2% 






5.5.2 ITC Measures of Self-Report Puffing Behaviour 
 
Three measures of self-reported puffing were included in the Wave 2 survey (“Butt 
Length,” “Puff Strength,” and the “Puff Number” scale). The Puff Strength question was 
re-administered at Wave 3, along with a measure of Puff Frequency.  As noted in the 
Methods section, all of the measures were derived from the field study of smoking 
behaviour. Table 20 shows responses to each of the five measures.  
 
Table 20. ITC self-report puffing behaviour (n=7,302) 
 
 CAN US UK AUS Total 
      
Butt length –Wave 2 (%)      
“Half or less” 11.2 15.3 11.0   5.5 10.8 
“Most of cigarette” 26.6 29.3 36.4 33.6 31.6 
“Nearly to the butt” 41.3 37.9 40.4 42.4 40.5 
“Right to the butt” 20.9 17.2 12.2 17.5 17.1 
      
Puff strength –Wave 2 (%)      
“Don’t inhale into chest at all”   2.9   2.8   3.4   2.3   3.0 
“A little into chest” 33.9 31.2 34.4 29.8 34.9 
“Deeply into chest” 48.1 51.0 37.3 41.8 48.2 
“As deeply as possible” 14.1 14.0 11.5 12.1 13.9 
      
Puff number –Wave 2 (%)      
“Only a few puffs” 10.0 10.4 10.3   6.6   8.8 
“More than few” 50.5 56.1 56.2 57.8 53.6 
“As many as you can” 39.5 33.5 33.5 35.6 37.6 
      
Puff strength –Wave 3 (%)      
“Don’t inhale into chest at all”   1.9   1.3   3.2   2.9   2.4 
“A little into chest” 33.5 36.3 42.8 35.1 36.8 
“Deeply into chest” 53.1 48.2 45.1 50.7 49.4 
“As deeply as possible” 11.5 14.2   8.9 11.3 11.4 
      
Puff frequency –Wave 3      














5.5.3 ITC Predictors of Self-Report Puffing Behaviour 
 
A linear regression was conducted to examine whether demographic variables and 
measures of consumption were associated with self-reported puffing behaviour. Each of 
the four measures of puffing behaviour served as the dependent variable in separate 
regression models. Appendix J includes full results for each model. Several patterns 
emerged across models. Cigarettes per day demonstrated the strongest association with 
each of the puffing measures: Butt length (Part r = .14, p<.001), Puff Strength (Part r = 
.15, p<.001), Puff Number (Part r = .18, p<.001), and Puff Frequency (Part r = .07, 
p<.001). Age was also significantly associated with each of the puffing measures: Butt 
length (Part r = -.09, p<.001), Puff Strength (Part r = -.09, p<.001), Puff Number (Part r 
= .10, p<.001), and Puff Frequency (Part r = -.15, p<.001). In other words, younger 
smokers and those who smoked more cigarettes per day consistently reported more 
intensive puffing. In addition, education level was negatively associated with Butt Length 
(Part r = -.03, p<.001) and Puff Strength (r = -.04, p<.001), intention to quit was 
negatively associated with Puff Strength (Part r = -.08, p<.001) and Puff Number (Part r 
= -.05, p<.001), and Income was negatively associated with Puff Strength (Part r = -.03, 
p=.02).  
 
Several country-level differences were also noted. Canadian respondents reported shorter 
Butt Lengths than US (Part r = .08, p<.001) and UK respondents (Part r = .08, p<.001), 
as well as a greater number of puffs than UK respondents (Part r = .05, p<.001). 
Canadian and US respondents reported stronger puffing than UK respondents (Part r = 
.05, p<.001 for both), whereas Australian respondents taking more frequent puffs than 
Canadians (Part r = .07, p<.001). No interactions were significant in any of the models. It 
should also be noted that the magnitude of the “significant” associations observed in 
these models is small. The significance of these variables is mainly a reflection of the 




5.5.4 ITC Brand-Related Predictors of Self-Report Puffing Behaviour 
 
One potential use of self-report measures in population-based surveys is to examine 
compensatory smoking behaviour in response to changes in cigarette brands. Among ITC 
respondents, brand-related information was only available for a sub-sample of 1,413 
Canadian respondents (71% of all Canadian respondents). For this sub-sample, ISO 
nicotine yields were matched with participants’ “usual” cigarette brand. The ISO nicotine 
yield was then entered in the final step of the linear regression models reported in Table 
20 (i.e. adjusting for cigarette consumption and demographic variables). As Table 21 
indicates, ISO yield was significantly associated with Puff Number and Puff Frequency; 
however, as in earlier models, the magnitude of these associations were modest.  
 
Table 21. Linear regression ISO nicotine yield (n=1,413)† 
 Beta* t value p value Part r 
Butt Length (Wave 
2) -.03 -1.25 .21 -.03 
Puff Strength .03 1.09 .28 .03 
Puff Number  -.05 -2.05 .04 -.05 
Puff Frequency -.07 -2.61 -.01 -.07 
† Adjusting for gender, age, education, income, CPD, and intention to quit 
 * Standardized Beta  
 
Overall, it would appear that the ISO nicotine yield was generally not related to measures 





5.5.5 Changes in Self-Report Puffing Behaviour Across Survey Waves 
 
As Section 5.5.3 indicated, Puff Strength was significantly associated with CPD among 
ITC respondents. The compensatory nature of cigarette smoking suggests that reductions 
in the number of cigarettes per day (CPD) or changes in cigarette brand may have 
implications for puffing behaviour, as participants attempt to regulate their nicotine 
intake. A linear regression was conducted to examine whether changes between Waves 2 
and 3 in CPD or “usual” cigarette brand were associated with changes in Puff Strength. 
(Recall that Puff Strength was the only self-report measure of puffing behaviour to be 
asked at both Waves 2 and 3 of the ITC survey.) First, there was a reasonably strong 
correlation between measures of Puff Strength at Waves 2 and 3 (r =.59, p<.001), 
suggesting moderate stability over time. The results of the linear regression failed to 
reveal any significant association between changes in Puff Strength, changes in CPD and 
usual brand smoking, or any of the demographic variables entered into the model (see 
Appendix K). Australian respondents reported somewhat fewer changes in puff strength 
relative to Canadian respondents (Part r = .03, p= .03), although the magnitude of this 
difference was modest. Overall, although there was a reasonable degree of change in self-
reports of Puff Strength between waves 2 and 3 of the ITC survey, this changes was not 





To our knowledge, this research represents the most comprehensive independent study to 
examine smoking topography, brand switching, and nicotine uptake outside a laboratory 
setting. This study also provides the first independent evidence on the parameters of 
puffing behaviour among Canadian smokers. These parameters were collected using 
novel technology that permitted “naturalistic” measures of puffing behaviour outside the 
laboratory setting. Overall, participants reported that the CReSSmicro device was easy to 
use, and caused only modest changes to their normal smoking behaviour. The “user-
friendliness” of the device is supported by the fact that participants smoked well over 
6,000 cigarettes through the device over the course of the study. 
 
 
6.1 Naturalistic Measures of Puffing Behaviour 
 
The puffing behaviour collected through the CReSSmicro device provides a unique 
opportunity to examine naturalistic measures of puffing behaviour among a sample of 
Canadian smokers. Overall, the data indicates a high degree of stability in puffing 
behaviour within the same smoker over time, but considerable variability between 
smokers. Total smoke intake –the amount of smoke participants inhaled from each 
cigarette—varied widely among individuals smoking their usual brand of cigarettes: 
participants in the top quartile of smoke intake inhaled approximately two and a half 
times the volume of smoke as individuals in the lowest quartile of smoke intake. Puffing 
behaviour also varied between male and female smokers. The results indicate that female 
smokers took more puffs per cigarette, but significantly smaller puffs than males, such 
that they inhaled less smoke overall, per cigarette, than males. This is consistent with 
previous laboratory-based studies of puffing behaviour96,97, as well as previous reports of 
lower cotinine levels among females.98,99   
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There are several reasons why females exhibit less intense puffing behaviour and lower 
overall levels of smoke intake. First, lower levels of smoke intake among females may 
reflect differences in the rate of nicotine metabolism among women, although the 
research is inconclusive on this issue.100, 101,102  Lower levels of intake among women 
may also reflect differences in body mass and size. Body mass is a factor in the clearance 
of nicotine from the body, whereas differences in lung capacity may account for the 
lower puff volume observed among females.101  Overall, the gender differences in puffing 
behaviour and nicotine uptake observed in the current study may have important 
implications for understanding risk-exposure among women. They make also have 
implications for understanding cigarette design: internal research documents from 
tobacco manufacturers indicate that some brands have been designed to respond to the 
less intense puffing patterns among women. For example, research from British 
American Tobacco found that slim cigarettes provide greater ease of draw compared to 
other “low-tar” cigarettes, and respond well to females’ lighter draw tendencies.102 
 
The results from the current study also indicate that puffing behaviour varied widely 
between smokers of a single brand. Indeed, the variability in smoke intake within the two 
most popular brands was equal to, or greater than the variability observed among all 
smokers. These findings highlight the importance of individual nicotine “thresholds” and 
their variability across smokers. Some individuals are simply lighter smokers and pursue 
lower levels of nicotine, whereas others smoking the same brand have higher nicotine 
thresholds and must smoke each cigarette more intensely. Differences in nicotine 
thresholds are related to an individual’s nicotine metabolism: individuals with faster 
metabolic rates need to smoke more intensely in order to regulate nicotine levels.101   
 
There is some evidence that smokers with greater nicotine thresholds smoke brands with 
higher ISO nicotine yields, although the extent of this self-selection appears to be 
relatively modest.51,103  In other words, each cigarette brand seems to recruit smokers 
with a range of nicotine thresholds and there is only a modest association between the 
nicotine yield of a product and puffing intensities for usual brand smokers. 39,104,105  The 
current findings are consistent with this research: puffing behaviour and cotinine levels of 
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participants varied widely within brands and there was no discernable association 
between ISO nicotine yield and the intensity of puffing among “regular-yield” brands.  
 
There was, however, a strong association between puffing behaviour and nicotine uptake 
among smokers. Total smoke intake, or inhalation volume, derived from measures of puff 
volume and puff number, was a strong predictor of nicotine uptake. The interaction 
between cigarettes per day and smoke intake was the strongest predictor of nicotine 
uptake measured in the current study. This interaction represents the total smoke 
exposure for each individual, taking into account both the total number of cigarettes and 
the smoke extracted from each cigarette. Overall, these findings suggest that individual 
differences in how each cigarette is smoked have important implications for overall risk 
exposure. 
 
In terms of the specific parameters of puffing behaviour, the current results for “regular” 
brand yields are somewhat more intense than previous research for usual-brand 
smoking,16 but generally consistent with more recent studies.106,107  As industry scientists 
have noted, widespread changes to cigarette designs, such as the introduction of filter 
ventilation, appear to have shifted the “normal” parameters of puffing behaviour toward 
more intensive smoking: "We have found a trend within the department for smokers to 
increase the volume of smoke drawn from cigarettes as the standard deliveries have been 
reduced by manufacturers.”108  The current findings may be further evidence of this 
trend. It should be noted, however, that the puffing parameters observed in the current 
study for “low-yield” smokers may be somewhat different than the parameters among 
those who smoke Matinee Extra Mild –the “low-yield” brand—as their usual brand. 
Nevertheless, the inhalation volumes among the “switchers” in the current study were 
consistent with data from other studies from those who smoke “low-yield” products as 






6.2 Changes in Response to a “Low-Yield” Cigarette Brand: Smoker Compensation 
 
This study provides strong support for behavioural compensation in response to changes 
in brand yield. The naturalistic measures of smoking topography are consistent with 
laboratory-based findings that smokers make substantial changes to their puffing 
behaviour when switching from “regular” to “low-yield” cigarettes in order to maintain 
their level of nicotine intake. The compensatory changes observed in the current study 
were stable, with no observable degradation over the course of five days.  It would appear 
that participants also attempted to compensate by increasing their daily consumption: 
participants who were switched to the “low-yield” brand increased their daily cigarette 
consumption by approximately 1.5 cigarettes or 8% per day while smoking the “low-
yield” brand. This is consistent with previous research which suggests that smokers 
compensate through changes in the number of cigarettes, as well as the intensity with 
which each cigarette is smoked.24,109  
 
Overall, the 12% reduction in salivary cotinine levels observed among the “low-yield” 
switchers was significantly less than the 64% reduction in nicotine yield when compared 
to their usual brand. Nevertheless, it would appear that most smokers stopped short of 
complete compensation. It simply may not have been possible for smokers to compensate 
for such a large change in nicotine yield, particularly while using the CReSSmicro 
device, which can interfere with filter vent-blocking (see Section 6.6, below). Perhaps for 
this reason, it is rare for smokers to switch between products with such a large 
discrepancy in nicotine yields, at least outside of research studies.  
 
The current findings are generally consistent with previous research on smoker 
compensation. For example, two of the largest brand-switching studies randomised 
substantial numbers of smokers to “low-yield” brands and followed them over a period of 
six months.110,111  In the one study,111 nicotine compensation was essentially complete; in 
the other, it was estimated to be approximately 80%.110  Studies of spontaneous brand 
switching depict the same pattern: smokers increase the intensity of their smoking to 
compensate for lower-yield products.24 These studies have important public health 
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implications. Smokers who spontaneously switch to a “low-yield” brand are often driven 
by a desire to reduce the health consequences of smoking and may result in some 
smokers delaying quitting.112  The current study contributes to the evidence on 
compensatory smoking, which negates most or all of the potential health effects of 
switching to a “low-yield” product.  
 
 
6.3 Testing Protocols and Human Smoking Behaviour 
 
In their 1936 paper, the originators of the Cambridge Filter Method state that cigarette 
testing protocols should, “sufficiently approximate the conditions of human smoking” 
(p.836).10   The results from the current study indicate that the ISO protocol fails this basic 
criterion. The findings indicate that the ISO testing parameters systematically 
underestimated every measure of puffing behaviour recorded among human smokers. 
The average smoke intake from the ISO regime ranked only in the 7th percentile of 
human smokers for “regular yield” brands, and fell below the lowest smoke intake among 
“low-yield” smokers. It should also be noted that the smoke collected through the ISO 
regime was drawn at a much lower flow-rate than was observed among human smokers 
(18ml/sec vs. 38ml/sec). Flow-rate has important implications for filter efficiency, as well 
as the proportion of diluting air that enters through the porous paper in the tobacco rod 
and through filter vents. As a consequence, flow rates affect the concentration of 
constituents, as well as the ratio of tar to nicotine.48 Flow rates are also associated with 
greater depth of inhalation and greater lung exposure to the toxic constituents in tobacco 
smoke.113  Indeed, the changes in inhalation patterns induced by “low-yield” cigarettes 
are thought to be responsible for an increase in the incidence of adenocarcinoma of the 
lung among smokers, a form of lung cancer that is specifically associated with deeper 
lung exposure.113,114   
 
The three alternative testing protocols examined in this study represented an 
improvement on the ISO method; however, none reflected “intensive” human smoking. 
The puffing parameters used in the Canadian and Massachusetts regimes fell somewhere 
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near the mean for “regular-yield” smoking, whereas the Compensatory protocol 
drastically underestimated the puffing parameters of “regular-yield” smoking, almost to 
the same extent as ISO. These results suggest that the “starting point” for the 
compensatory regime (40ml puffs drawn every 60 seconds) was simply too low. For 
“low-yield” smoking, all three alternative protocols drastically underestimated human 
puffing parameters. The Compensatory regime was closest to the actual smoke intake for 
“low-yield” smoking, although it still only ranked in the 42nd percentile of human 
smokers.  
 
It may seem counter-intuitive that the Canadian regime did not generate greater smoke 
intake than the Massachusetts regime, given the greater intensity of the puffing 
parameters (55ml puffs and 100% vent blocking vs. 44ml puffs and 50% vent blocking, 
respectively). However, more intensive puffing and complete ventilation blocking has the 
effect of increasing the burn rate of the cigarette. In other words, larger, faster puffs that 
are drawn with the filter ventilation completely blocked consume more of the cigarette 
rod with each puff and reduce the total burn time of the cigarette. Because the Canadian 
and Massachusetts regimes draw puffs at the same frequency, the more intensive puffing 
parameters of the Canadian regime resulted in a lower number of puffs per cigarette as 
the cigarette rod was consumed more quickly (11.2 vs. 13.7, respectively). Nevertheless, 
as the following section indicates, the Canadian regime generated more concentrated 
smoke per puff, and produced greater constituent yields than the Massachusetts regime 
for every cigarette tested in the current study. 
 
 
6.4 Testing Protocols, Cigarette Yields, and Human Exposure 
 
The Human Mimic regime provided an opportunity to evaluate the ISO, Massachusetts, 
Canadian, and Compensatory cigarette yields, against yields generated under “realistic” 
human smoking conditions. For “regular-yield” brands, the results from the Mimic 
regime suggest that smokers typically ingested double the tar, nicotine, and carbon 
monoxide than was indicated by either the ISO and Compensatory regimes. The 
 75
Massachusetts regime generated yields closest to the Mimic yields for regular-yields 
brands, whereas the yields from the Canadian regime were somewhat higher than the 
mean Mimic yields.  
 
For the “low-yield” brand, the discrepancy between the ISO and Mimic yields was even 
greater than for “regular-yield” brands: the Mimic regime suggests that participants were 
exposed to tar, nicotine, and CO levels more than four times greater than the ISO yields. 
Both the Massachusetts and Compensatory protocols fell slightly below the mean Mimic 
yields, whereas the Canadian yields were slightly above the mean.  
 
Overall, the constituent yields from the different testing protocols are consistent with 
what one would expect from the testing parameters: the ISO regime systematically 
underestimated exposure for all brands; the Compensatory regime failed with respect to 
“regular-yield” brands; whereas the Massachusetts and Canadian protocols were 
generally at or slightly above the mean of human measures of intake and exposure. It 
should be noted that both the Canadian and Massachusetts protocols were originally 
designed to reflect intensive smoking conditions; in fact, the Canadian protocol is often 
referred to as a “maximum” smoking regime. However, the current results would seem to 
suggest that these regimes reflect “average” smoking conditions, rather than intensive 
ones. Given that the majority of Canadian, U.S., and U.K. consumers smoke “low-yield” 
brands, these alternative protocols may even fall short of the average smoke intake for the 
vast majority of smokers.115,116 
 
As Section 5.3.1 indicated, there was some discrepancy between the mean number of 
puffs recorded from participants and the number taken by the Filtrona machine when 
conducting the Human Mimic regime. This discrepancy generated 17% more smoke for 
“regular-yield” brands and 7% less smoke for the “low-yield” brand compared to mean 
inhalation volumes recorded from participants. As a result, the Mimic values for “regular-
yield” brands may be slightly exaggerated, whereas the “low-yield” values may represent 
a slight underestimate. 
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To our knowledge, this is the first independent study to use brand elasticity to predict 
nicotine uptake. Brand elasticity functions as a type of summary measure for how 
different product features, such as filter ventilation, interact with smoker behaviour to 
produce different patterns of exposure. (Ideally, these product variables would be entered 
directly into the analytical models; however, they were unavailable for the current 
analysis.) The elasticity variable used in the current study was associated with cotinine 
levels, but not to a greater extent than cigarettes per day and measures of intake alone. 
One potential explanation for this null finding is that the brand data used to calculate 
elasticity was almost ten years old. Tobacco manufacturers periodically make design 
changes to their brands and any changes over the past ten years to the brands in the 
current study would introduce measurement error into the elasticity variable and reduce 
the likelihood of detecting “actual” differences between the brands.  
 
Further research is needed to evaluate the value of brand elasticity as a predictor of 
exposure. However, as Jarvis et al. have noted51, nicotine preferences, rather than product 
features, seem to be the most important determinant of nicotine deliveries. Design related 
factors that appear to deliver differences under the ISO testing protocol, are typically 
“over-ridden” by compensatory behaviours. It should be noted that all of the cigarettes on 
the Canadian market have more than enough nicotine to satisfy even “high threshold” 
smokers without requiring unreasonable puffing intensities. It is not the case that “low-
yield” cigarettes are made from low-nicotine tobacco; rather, the total nicotine content 
from “low-yield” products is typically equal to or even greater than the nicotine content 
in “regular-yield” products.117,118  It is only under the deceptive testing conditions of the 
ISO protocol that “low-yield” brands appear to contain less tar and nicotine. Indeed, 
“low-yield” status is almost entirely due to the smoke dilution through the filter vents 
under the ISO protocol118: a secondary analysis of Phillip Morris data119 revealed an 
almost perfect correlation (r = 0.93, p<.001) between ISO nicotine yield and the 
percentage of filter ventilation.120 In other words, it isn’t the case that the smoke from 
ventilated cigarettes is inherently different than smoke from unventilated brands; rather, 
the “low-yields” simply reflect the fact that the ISO regime draws in a considerable 
proportion of air mixed with the smoke, when testing cigarettes.  
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The effect of filter ventilation is also apparent in the concentration of nicotine and tar in 
cigarette smoke. The results provide a comparison on nicotine and tar yields from the 
ISO regime (0% ventilation blocking) and the Canadian regime (100% ventilation 
blocking) that illustrates this effect. Among the low ventilated “regular-yield” brands 
there is only a 10% increase in the concentration of nicotine, and a 20% increase in the 
concentration of tar from the ISO to the Canadian regimes. However, for the highly 
ventilated “low-yield” brand, the nicotine concentration increased by 82% and the tar 
yield increased by 142%. In other words, once the filter ventilation is blocked, the 
concentration of the smoke constituents increases significantly, and “low-yield” products 
begin to perform much the same as “regular-yield” brands. Overall, filter ventilation 
allows smokers to titrate their nicotine more effectively. In short, smokers can and do 
extract whatever level of nicotine they desire from virtually any brands on the market.  
 
The variability in puffing behaviour and cotinine levels has important implications for 
how cigarette yields should be interpreted. The current results suggest that the yields 
from the Massachusetts and Canadian protocols are no better at predicting cotinine levels 
than ISO yields. Indeed, even the Mimic yields, which were derived from actual puffing 
behaviour, were only moderately correlated with salivary cotinine levels. Given the 
heterogeneity of smokers using each brand, there are inherent limitations to using a single 
mean value to predict individual exposure. As the current study demonstrates, this 
limitation is present even if the mean puffing parameters for each brand can be accurately 
predicted and replicated by the machine. In short, no testing protocol will be capable of 
providing accurate individual estimates of exposure.  
 
Some observes have suggested that one way to make cigarettes yields more relevant to 
individual smokers may be to express cigarette yields in terms of ratios to nicotine.7 If 
nicotine is the driving force behind smoking behaviour, then it may make sense to 
“anchor” yields to nicotine. In other words, nicotine ratios help to “adjust” for the fact 
that individuals extract different levels of nicotine, and communicates the proportion of 
toxic constituents (e.g., tar) that smokers might expect from a brand when reaching their 
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nicotine level. This approach rests upon the assumption that, although the total amount 
and concentration of tar and nicotine change under different smoking conditions, the 
ratios of constituents are relatively fixed. However, as the current results indicate, the 
ratios do change across smoking conditions. For example, the ratio of tar/nicotine for the 
“low-yield” brand tested under the ISO regime increased by 36% when the same brand 
was tested under the Canadian regime. This suggests that smokers who reach their 
nicotine threshold under puffing conditions similar to the Canadian regime stand to ingest 
36% more tar compared to smokers who reach the same nicotine threshold only under the 
less intensive puffing parameters of the ISO regime. In short, tar and nicotine ratios are 
not constant across different smoking conditions, at least not to the extent that is 
commonly assumed. As a consequence, expressing cigarette yields as nicotine ratios is 
unlikely to make machine tested cigarette yields much more relevant to individual 
smokers. 
 
Several researches have noted that many of these issues might be minimized by 
comparing cigarette brands at the same nicotine level. Each of the “standard” testing 
regimes (i.e., the ISO, Massachusetts, and Canadian regimes) test different brands at the 
same puffing conditions; however, the different design properties of brands ensure that 
these puffing conditions produce much different levels of nicotine within the same testing 
protocol. For example, for brands in the current study, the smoking conditions used by 
the Canadian regime produce nicotine yields with a range between 1.6 and 2.8mg. As a 
consequence, the denominator for the tar/nicotine ratios differs across brands tested under 
the same protocol. To compare ratios from similar doses of nicotine (i.e., to ensure that 
the denominator in the tar/nicotine ratio is the same across brands), some brands would 
need to be smoked at much more intensive levels.  
 
The Compensatory regime tested in the current study attempts to accomplish this by 
varying the smoking conditions in an attempt to equalize nicotine levels across brands. 
However, as the current results indicate, the Compensatory puffing regime was not 
successful in mirroring the differences in human smoking behaviour across brands. As a 
consequence, instead of achieving a nicotine yield of 1mg across all brands, the 
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Compensatory regime yielded a range between 0.8 and 1.2mg. The Human Mimic 
nicotine yields would also suggest that using 1mg of nicotine as the benchmark for 
exposure is too low. Other compensatory alternatives have recently been suggested and 
are currently under consideration by a WHO committee charged with the responsibility to 
revise the ISO regime.121  
 
Overall, the current results indicate that, whatever metric is used to express cigarette 
yields—absolute levels, concentrations, or ratios—testing protocols must account for two 
fundamental realities of human smoking behaviour: 1) There is great natural variability in 
puffing behaviour within any one brand, and 2) Smokers will adjust their behaviour when 
switching products to account for differences in design and nicotine delivery. The 
findings indicate that none of the testing protocols examined in the current study fully 
account for realities. However, this is not to suggest as the tobacco manufacturers have 
argued, that the ISO regime is no worse than the other alternatives examined in the 
current study. The ISO regime systematically underestimates risk exposure, and 
exaggerates the differences between ventilated and un-ventilated brands to a far greater 
extent than the other testing regimes. This was true for regardless whether one consider 
the absolute levels, concentrations, or ratios of nicotine, tar, and carbon monoxide. In 
short, the ISO protocol introduces deceptive differences between brands that, when 
communicated directly to smokers, are prone to misunderstanding and misuse.  
 
 
6.5 Self-report Measures of Smoking Behaviour 
 
To our knowledge, this was the first study to attempt to validate self-report measures of 
puffing using physiological measures of smoking behaviour. The results from the field 
study suggest modest correlations for certain parameters, such as Puff Frequency, and to 
a lesser extent for measures of Puff Depth and Puff Number. There was a trend towards 
higher correlations in the Post-Trial surveys, compared to the recruitment telephone 
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survey. It may be that using the CReSSmicro device and participating in the study may 
have caused respondents to become more aware of their puffing behaviour.  
 
There were several inconsistencies noted in the self-report data. For example, the Post-
Trial survey measures of Puff Depth and Puff Frequency were correlated at .80 (p<.001) 
at Trial 1, but only .18 at Trial 2 (p=.22), and .14 at Trial 3 (p=.34). The reasons for these 
discrepancies are unclear. There were also inconsistencies across the models predicting 
intake and exposure. For example, Puff Depth and Butt Length predicted levels of 
cotinine at Trial 1 in cross-sectional analyses; however, Puff Strength and Puff Number 
were associated with changes in cotinine between Trials 2 and 3. However, there was a 
general pattern in which one measure of either Puff Depth or Strength, and one measure 
of puff number—Puff Number, Frequency, or Butt Length— were present in each of the 
models. Given that puff volume and puff number are the two determinants of smoke 
intake, this is consistent with what one might expect.  
 
It is not entirely clear, however, why the individual variables varied across models. One 
possibility is that some self-report measures may be less sensitive to changes, perhaps 
because the size of meaningful differences may escape awareness. For example, a 20% 
difference in puff frequency only amounts to approximately 6 seconds for the average 
participant. This magnitude of change may simply escape detection.  
 
Given the high frequency, recentness, and apparent stability of puffing behaviour, it 
seems unlikely that some of the biases and cognitive errors typically associated with 
retrospective self-reports, such as telescoping, would be responsible.122  However, the 
cognitive phenomenon known as “rounding” may be at play for open-ended measures of 
Puff Number and Puff Frequency. Rounding occurs when respondents give prototypical 
answers to questions, such as rounding time into minutes, rather than seconds. More 
generally, the distribution of responses for some of the self-report measures raises 
questions about their structure. For example, very few respondents endorsed the “lowest” 
response categories for the Puff Number scale and Puff Depth. This suggests that at least 
some of the response options could be revised to better discriminate between the smokers 
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clustered in the remaining categories. Some of the response options may also have been 
unclear to respondents. For example, the Puff Strength measure was intended to provide 
physiological reference points for respondents. However, “mouth,” “throat,” and “chest” 
were all included as reference points and may have caused confusion among respondents 
as to the ordinality of the measures. In other words, “inhale well back into your mouth” 
may have been construed by some respondents as more intense than “…only partly into 
your chest.” Overall, the self-report measures included in this study would benefit from 
additional pilot-testing and perhaps some qualitative research to identify more intuitive 
phrasing or reference points to improve the reliability of responses.   
 
The results from the ITC survey provide some support for moderate correlations between 
the age of smokers, daily cigarette consumption, and the intensity of self-report puffing. 
Several between-country differences were also observed, but the magnitude of these 
differences was modest, and their statistical significance is primarily a reflection of the 
large sample size.  
 
There was no association between the ISO nicotine yield of brands and self-report 
puffing behaviour, or changes to cigarette brands and changes in self-report puff strength. 
It should be noted, however, that these analyses were limited both by the number of self-
report measures included in the ITC survey, as well as a lack of brand-specific data. For 
example, changes in cigarette brands between waves 2 and 3 of the ITC survey would 
only be expected to result in changes to puffing behaviour if the brands were significantly 
different in some meaningful way, such as the tobacco blend or filter ventilation level. 
Changes in puffing would not be expected if the brands were generally similar versions 
of the same product, but from different manufacturers, for example. The current analyses 
were not able to make this distinction and, therefore, may obscure meaningful 
associations between brands and self-report. 
 
Subsequent to the completion of this study, we became aware of another study to have 
examined the validity of self-reported measures of puffing.123  Etter and Perneger had 
participants complete a survey and correlated these measures with salivary cotinine 
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levels. Two self-report measures produced significant bivariate associations with 
cotinine: a smoking intensity question (“Indicate on a scale between 0 and 100, the 
intensity of your smoking”) and a quantity of smoke question (“What is the total quantity 
of smoke that you inhale every day? This quantity depends upon the number of cigarettes 
you smoke, the depth of inhalation, the number of puffs, etc.”) The smoking intensity 
variable was significantly associated with cotinine after adjusting for cigarettes per day, 
and type of cigarette (full flavour, etc.).  
 
Kozlowski and colleagues have also examined self-report measures in the related area of 
cigarette vent blocking. Overall, this research suggests that self-report vent blocking is 
largely unrelated to actual blocking: many smokers whose cigarette butts confirm vent-
blocking fail to report covering the vent holes, while at the same time, there is often little 
objective evidence of blocking among smokers who report having done so.103,124   
 
Overall, the current findings provide only limited preliminary support for the validity of 
self-report measures of puffing behaviour. However, given the potential value of self-
report measures, this area warrants further research. For example, in October 2005, in an 
effort to reduce cigarette-related fires, Canada will implement the first national regulation 
on cigarette ignition propensity. The law will require cigarettes to self-extinguish 75% of 
the time when tested according to a standard protocol.125 Although extensive testing 
suggests that the new restrictions will indeed reduce the ignition propensity of cigarettes, 
the tobacco industry has actively opposed the legislation on the grounds that the changes 
required to design reduced ignition-propensity cigarettes may be more toxic to 
smokers.126 Valid measures of self-reported puffing behaviour would help to evaluate any 
such changes in puffing behaviour and smoke intake among Canadian smokers, relative 





The current study has several limitations. First, the participants in the field study were not 
necessarily representative of smokers in the population at large. We selected a sample 
that smoked “regular-yield” brands and who were not planning to quit in the near future. 
Nevertheless, the current study provides data from over 20 different cigarette brands, 
including a range of nicotine and tar yields.  
 
A second limitation is that smokers were provided with only one “low-yield” brand when 
switching down from their usual brand.  This was done to control for differences across 
brands, but the results may not translate to what happens when smokers spontaneously 
switch to a “low-yield” brand of their choice. In addition, the design did not control for 
any “novelty effect” in the brand-switching condition. However, the increases in puffing 
behaviour and smoke intake are entirely consistent with previous research and we did not 
observe any attenuation or degradation of this effect over the course of 4 to 5 days of 
“low-yield” smoking, as would be expected with a novelty effect.  
 
A third limitation concerns vent-blocking. Measures of vent-blocking were not collected 
from participants in the field study. As a result, the vent-blocking conditions for the 
Human Mimic testing were set at 50%, based upon the few population based studies that 
have been conducted.103  This limitation is mitigated somewhat by the fact that most of 
the twenty “regular-yield” brands included in the study were either un-vented or had 
minimal ventilation. As a result, lip and finger placement on the filter would have had 
little or no effect on the levels of tar, nicotine, or carbon monoxide delivered to 
participants. However, measures of vent-blocking would have been informative in 
assessing compensation to the ventilated Matinee Extra Mild brand in the “low-yield” 
condition.  
 
It should also be noted that using the CReSSmicro device may interfere with 
“naturalistic” vent-blocking. When cigarettes are inserted into the device, the perforations 
on the cigarette filter sit immediately outside the mouthpiece. Participants may find it 
awkward to grip the filter directly, and those who do may not obscure the vents in the 
usual fashion. One consequence is that “low-yield” smokers may have increased the 
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intensity of their puffing behaviour to compensate for the diluted smoke from the 
unblocked vents.  
 
A fourth limitation concerns the use of salivary cotinine as the “gold standard” for 
assessing intake. As indicated earlier in the discussion, cotinine levels vary somewhat 
over the course of a day and also subject to individual differences in metabolism. Future 
studies should try to standardize the time of saliva collection in order to minimize the 
variability associated with this measure.  
 
Finally, these findings should be generalized to smokers in other countries with caution 
because it is known that Canadian cigarettes differ from other international brands on 
several important features –including tobacco blend, additives, and processing.127,128   
 
Future research should consider measuring individual smoke constituents, rather than tar 
alone. Although tar is often referred to as a single substance, it includes more than 3,500 
different compounds, 55 of which have been identified as possible human carcinogens.129 
Clearly, tar is not a homogeneous substance and its use as a measure of toxicity obscures 
critical differences in the amount and importance of individual chemicals in tobacco 
smoke. Indeed, similar levels of tar have markedly different compositions across different 
products, different markets, and even within the same product tested under different 
testing protocols.130 As a consequence, future testing protocols and regulatory standards 
should be based upon key individual smoke constituents, rather than the misleading 
notion of tar.  
 
Future research should also incorporate physical design measures into analytical models. 
Variables such as the percentage of filter ventilation, tobacco weight, paper porosity, and 
tobacco blend can account for as much as 90% of the variation between brands in 
cigarette yields. These design features interact with human smoking behaviour to 
determine the toxicity of the product, and should feature more prominently in 
independent research. For example, including these variables into the ITC data set would 
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allow for more sophisticated analyses to examine potential associations between self-





Cigarette testing protocols have important implications for risk communication and 
regulations intended to reduce cigarette toxicity. Article 9 of the Framework Convention 
on Tobacco Control (FCTC) includes provisions for testing the contents and emissions of 
tobacco products, as well as for regulating these contents and emissions. As the FCTC is 
ratified by a growing number of countries, there is an urgent need to articulate an 
alternative to the ISO regime and to stipulate the provisions included in Article 9.  
 
In May 2005, the International Standards Organization convened a working group to 
revise the testing protocols (ISO TC 126 WG9). Of the 32 experts in attendance, 11 were 
from public health agencies and 17 were from the tobacco industry. The objective of the 
ISO working group is to develop “…a robust and practical smoking regime that as far as 
possible is representative of smokers’ behaviour.”  In contrast, the World Health 
Organization’s own committee, TobReg, has stated the need for a testing regime that will 
“…approximate the maximum exposure level to which an ordinary smoker could 
reasonably be expected to be subject when smoking the specific product.”75  
 
As these parallel initiatives proceed, both groups should bear in mind the limitations of 
machine testing protocols. As the current findings help to demonstrate, cigarette yields 
are not indicators of health risk, and a reduction in constituent yields does not constitute a 
reduction in risk. The potential risk of a product must take into account how people use 
the product (e.g., whether they compensate for reduced yields by increasing their intake), 
as well as incentives for people to use the product –such as making the cigarettes “easier 
to smoke”— that may delay quitting among existing smokers or facilitate smoking 
initiation. Biological indicators of disease and epidemiological data are the only 
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appropriate measures of reduced harm. Hence, cigarette emission testing should be only 
one component of a comprehensive testing program that includes measures of human 
intake (e.g. puffing topography), biological measures of exposure, and indicators of 
disease. These realities will not change, regardless of how the ISO testing protocol is 
revised.  
 
Perhaps most important, cigarette yields should not be communicated as indicators of 
intake or risk exposure in any form. Until there is persuasive evidence to indicate that the 
differences in cigarette yields reflect meaningful differences in health risk, there is no 
benefit to presenting them directly to consumers, who will inevitably interpret lower 
yield products as less hazardous. In addition, the differences in yields must be large 
enough that they will not be easily overridden by compensatory behaviours, such as 
changes in puffing, or changes to the way the cigarette is held. There is a growing 
consensus that the ISO yields should be removed from all cigarette packages, and this 
appears set to happen in both Canada and Australia.75  In addition, the tobacco industry 
should be restricted from using ISO yields in any of its advertising or marketing directed 
at consumers, even if they are accompanied by “warnings” or disclaimers, such as those 
that currently appear in the United States. 
 
Nevertheless, various regulators are seeking to regulate the levels of known toxicants in 
cigarette smoke, and there is a need for a standardised method of generating the smoke 
from which to measure these toxicants. Several proposals are currently under review by 
the ISO working group and WHO’s TobReg committee. Beyond the questions 
surrounding the actual testing parameters, other important questions confront these 
groups, including how, if at all, cigarette yields should be regulated, as well as how to 
communicate risk to smokers without using quantitative yields. Alternative approaches, 
such as the use of descriptive information on smoke constituents, have been proposed and 






Overall, the current findings underscore the serious flaws in the current international 
testing regime. The ISO testing protocol is based upon entirely unrealistic smoking 
parameters that lead to deceptively low cigarette yields and create artificial distinctions 
between cigarette brands. Failure to remove or revise these methods will only perpetuate 
this deception and substantiate false industry advertising.   
 
The tobacco industry has been anticipating a change in the testing protocols for several 
decades. A senior executive from British American Tobacco summarized the industry’s 
position in 1984, as follows:  
 
The [Federal Trade Commission], and other authorities, may call for a change 
in the standard smoking machine test procedure. Around the group, the 
strategy, therefore, should be to do everything possible to maintain the present 
standard test procedure. If, however, the FTC or any other authority takes 
action to change the procedure, the strategy should then be to stretch out the 
discussions (both with the authorities and later at ISO) until exhaustive studies 
have established that an alternative procedure was in fact more relevant.131  
 
It is critical that the process of revising the testing protocols be guided by the interests of 
public health. The current findings represent one of the early attempts to build the 
evidence base on the leading candidates to replace the ISO testing regime. To this end, 
the current results highlight the need to develop tools to evaluate human exposure and 
smoking behaviours. More effective and less intrusive physiological measures will be 





7.1 APPENDIX A: Phone Survey 
 
 




Hello, my name is _______ and I am calling from the Survey Research Centre at the 
University of Waterloo. We are conducting a research survey on smoking. Can I ask 
someone 18 years of age or over a few questions to see whether anyone in your household 
qualifies for the survey?   
 
1 - Yes   Go to elig  
2 - Child-no adult available Go to child 
3 - No adult smoker in household Go to Ineligibility statement 
4 - No adult in household         Go to Ineligibility statement 




I would like to speak to an adult age 18 or older in your household who smokes 
- is there a better time to call back to speak to them? 
 
1 - Yes                        May we speak to them now?  goto intro2 
2 - No adult smokers in household    Thank you for your help.   end 




How many people age 18 or older live in your household, including yourself? 
[enter number] 
 
 How many of these adults, including yourself, smoke cigarettes at least daily? 
[enter number] 
 
 I'd like to speak to the smoker in your household who is at least 18 years old whose birthday 
is coming up next. Would that be you?    
1=if person on phone     goto elig 
2=if     other smoker       Can I speak to that person now?  If yes: repeat intro 
 
IF NECESSARY:   
We need to select somebody at random. With each call we make, we ask to speak to the 
person whose birthday is coming up next. This helps us to ensure that we have a 




How many years have you smoked?   if less than 1 year,   goto Ineligibility statement 
 Do you smoke every day or less than every day?  
0= Less than everyday  goto Ineligibility statement 
1= Every day 
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 Have you smoked 100 or more cigarettes over your lifetime? 
0= No           goto inelig 




We are looking for smokers who would be willing to answer a survey on smoking behaviour 
that is part of an international research project. The survey would take about 20 minutes. 
Your answers to this survey will be kept absolutely confidential. All personal information, 
including your name and address, will be kept strictly confidential and will not be shared 
with any person or group that is not associated with this survey. Finally, the survey has 
received ethics clearance from the Office of Research Ethics at the University of Waterloo. 
 
Would you be willing to participate in the survey? 
1 - yes           goto consent1 




Thanks for your help. Please let me know if you'd like to skip any questions you'd prefer     
not to answer. There are no right or wrong answers- we're most interested in                      
your personal opinions and you can decide to stop answering questions at any time.  




 I'm sorry to have reached you at a busy time. The survey will only 
 take a few minutes and we could really use your help for this study. If 
 this is an inconvenient time, could I call you back at another time? 
 1 - yes          goto reschedule 
 2 – no           goto thanks 
 
thanks   Thank you for your help, sorry to have bothered you.  
 
 




On average, how many cigarettes do you smoke each day, including both factory-made and 





Do you smoke factory-made cigarettes, roll-your-own cigarettes, or both? 



















Is there any difference between the number of cigarettes you smoke during a workday and 






What brand of [cigarettes/ roll-your-own cigarettes] do you smoke more than any other?  
 
7. brandfrq In the last 6 months, how often did you smoke this brand? READ  
01 – Always 
02 – Almost always 
03 – About half of the time 




How soon after waking do you usually have your first smoke? (Do not read) 
01 – minutes [enter] 




Do you consider yourself addicted to cigarettes? Would you say… READ 
01 – Not at all 
02 – Yes–somewhat addicted 





How hard would you find it to go without smoking for a whole day? READ 
01 – Not at all hard 
02 – Somewhat hard 
03 – Very hard 




Are you planning to quit smoking: READ 
01 – Within the next month?  
02 – Within the next 6 months?  
03 – Sometime in the future, beyond 6 months  
04 – Not planning to quit  
 If 1,2,3  goto Q.Quitdat 




Have you set a firm date? 
01 – Yes 




If you decided to give up smoking completely in the next 6 months, how easy or hard would 
it be? READ 
01 – Not at all hard 
02 – Somewhat hard 
03 – Very hard 










Of all the times you tried to quit smoking, what was the longest period you stayed off 







What is the highest level of formal education that you have completed? DO NOT READ  
01 – Grade school or some high school 
02 – Completed high school 
03 – Technical or trade school or community college (some or completed) 
04 – Some university (no degree) 
05 – Completed university degree 
06 – Post-graduate degree 
 
 I’m now going to ask you some question about how you smoke. Try to answer each one as 




When you smoke, how much of the cigarette do you usually smoke? READ 
01 – Right to the butt 
02 – Nearly to the butt 
03 – Most of the cigarette 




Which of the following best describes how strongly you usually inhale when you smoke? 
READ 
01 – You inhale as deeply into your chest as possible 
02 – You inhale only partly into your chest 
03 – You inhale as far back as your throat 
04 – You inhale well back into your mouth 




Which of the following statements best describes how many puffs you usually take when 
you smoke a cigarette? READ 
01 – You only take a few puffs on each cigarette 
02 – You take more than a few puffs, but not as many as you could 









When you smoke, how deeply do you inhale? READ 
01 – Not at all deeply 
02 – Somewhat deeply 
03 – Very deeply 











After you light a cigarette, how often do you usually put your cigarette down or hold it away 
from your mouth when you smoke?  
01 – Never 
02 – Not at all often 
03 – Often 




How do you usually hold a cigarette when you smoke it? Do you: READ 
1 – rest the cigarette between 2 fingers  
2 – hold or pinch the filter between two fingers 




Do you usually cover the filter with your hand while smoking? READ 
1 – Not at all 
2 – A little bit 
3 – A lot 




Are each of the following statements true or false: 
 
The way a smoker PUFFS on a cigarette can affect the amount of tar and nicotine a smoker 
takes in. 
1 – True 




The way a smoker HOLDS a cigarette can affect the amount of tar and nicotine a smoker 
takes in. 
1 – True 




Filters reduce the harmfulness of cigarettes. 
1 – True 




The nicotine in cigarettes is the chemical that causes most of the cancer. 
1 – True 
2 – False  
 
30. age What is your current age?  
[enter] 
 
31. sex Note sex (ask only if necessary) 
1 – Male 





Which of the following categories best describes your annual household income, that is the 
total income before taxes, or gross income, of all persons in your household combined, for 
one year? READ 
 
01 – Under $10,000 
02 – $10,000 to $29,999 
03 – $30,000 to $44,999 
04 – $45,000 to $59,999 
05 – $60,000 to $74,999 
06 – $75,000 to $99,999 
07 – $100,000 to $149,999 




People in Canada come from many racial and cultural groups. I am going to read you a list. 
Are you: (READ) 
 
IF RESPONDENT ANSWERS “MIXED” OR “BIRACIAL” PROBE FOR 
SPECIFIC GROUPS (E.G., “WHITE”, “BLACK”).  (Check all that apply) 
 
01 – White 
02 – Chinese 
03 – South Asian (for example, East Indian, Pakistani, Sri Lankan, etc.) 
04 – Black 
05 – Filipino 
06 – Latin American 
07 – Southeast Asian (for e.g., Cambodian, Indonesian, Laotian,Vietnamese, etc.) 
08 – Arab 
09 – West Asian (for example, Afghan, Iranian, etc.) 
10 – Japanese 
11 – Korean 
12 – Aboriginal (that is, North American Indian, Métis, or Inuit), or 




In addition to this telephone number, are there any other telephone numbers, not including 
cell phones, connected in your home? 
 
1 – Yes        goto lines 




How many, if any, of these, are used mainly for personal calls, rather than business calls, 





Those are all my questions- thank you for your help. Before we close, I’d like to mention 
that the University of Waterloo is conducting a related study on smoking behaviour. This 
related study is part of an international project using cutting edge technology to examine 
smoking behaviour. Very briefly, the study involves smoking cigarettes through a little 
hand-held device that would measure how much you puff on your cigarette and how deeply 
you puff. The device fits in the palm of your hand and your cigarette will fit in the 
mouthpiece- it does not interfere with the smoke from the cigarette and is easy to use. We 
will be providing adult smokers in the Waterloo region up to $180 in appreciation for their 
participation. We will be selecting participants within the next week, would you be 
interested in hearing more about the study at that time?    
If yes:  That’s great. When would be a convenient time to reach you?  




Thank you again for your time. Do you have any questions about the survey?  
If you have any further questions about your participation in the survey you are welcome to 
contact Dr. Susan Sykes at the Office of Research Ethics at the University of Waterloo, or 






7.2 APPENDIX B: Telephone Recruitment Script 
 
Recruitment Script 
Hello, my name is _________________ and I’m calling from the University of Waterloo 
about the smoking study. I’m calling to arrange a time for the next week during which 
you’ll be using the device- is now a good time? 
 
Just before we book a time, I’d like to go over the next few steps in the study. As you’ll 
recall, we’d like you to use the device for another week from _________ [dates], exactly 
as before. Just like before, we’ll pay you up to $60 for your time.  
 
We’d then like you to use the device for one final week. This week, from ____ to ____ 
[insert dates], will be the same, except that we will be asking some participants to use the 
device while smoking a different brand of cigarette than your regular brand. We will 
select these participants at random immediately before this final week: we will be 
providing you with a supply of cigarettes free of charge for this last week ,regardless of 
whether you will be selected to smoke your regular brand or a different brand. We’ll pay 
you another $60 for this last week of using the device. 
 
If you are selected to smoke a different, the cigarette brands will be major brands, only a 
lighter-yield from your own. In order to participate in the next stage of the study, you 
would need to agree to smoke another brand if you were to asked to do so in the last 
week. Would that be OK? 
 
Finally, as before we will be asking you collect cigarette butts, fill out a daily diary and 
provide a saliva sample at the end of each week.  Of course, all of the data you provide 
would be absolutely confidential and no one outside of our research team would ever see 
your individual responses or measurements.  
 
Do you have any questions? 
 
I’d like to arrange a time to drop off the device Would it be more convenient for you to 
visit us at our lab on the University of Waterloo campus, or would you prefer that we 
send 2 of our research assistants to your home?  
 
Day:______________________  Time:__________________ 
 
[For participants travelling to UW, we will provide them with a map and directions in the 
information letter.] 
 
Many thanks for agreeing to be in this field study. We will see you on [day] at [time]. 
We will give you a call the day before to confirm the appointment. If you need to contact 
us for any reason, here is our phone number: 888-4567 x3507.  Before we go, are there 
any questions I can answer for you? 
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*Note: Questions to be read out loud to participants 
 
1a. How much of the cigarette did you usually smoke when using the device? 
 
1 – Right to the butt 
2 – Nearly to the butt 
3 – Most of the cigarette 
4 – About half of the cigarette or less 
 
2a. Which of the following best describes how strongly you usually inhaled when you smoked, 
when using the device?  
 
1 – You inhale as deeply into your chest as possible 
2 – You inhale only partly into your chest 
3 – You inhale as far back as your throat 
4 – You inhale well back into your mouth 
5 – You just puff, you don’t really inhale 
 
3a. Which of the following statements best describes how many puffs you usually took when 
you smoked a cigarette using the device?  
 
1 – You only take a few puffs on each cigarette 
2 – You take more than a few puffs, but not as many as you could 
3 – You take as many puffs as you can on each cigarette 
 
4a. On average, how many puffs did you take on each cigarette when using the device 
___________ (please write number) 
 
5a. How deeply did you normally inhale when smoking using the device? 
 
1 – Not at all deeply 
2 – Somewhat deeply 
3 – Very deeply 
4 – As deeply as possibly 
 
6a. On average, how long did you let the cigarette burn in between puffs hen using the device?  
___________ (enter number of seconds) 
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7a. How often did you usually put your cigarette down or hold it away from your mouth after 
lighting a cigarette when using the device? 
 
1 – Never 
2 – Not at all often 
3 – Often 
4 – Very often 
 
8a. How did you usually hold a cigarette when you smoked using the device? Did you:  
 
1 – rest cigarette between 2 fingers  
2 – hold or pinch the filter between two fingers 
3 – hold or pinch the filter between more than 2 fingers 
 
9a. Did you usually cover the cigarette filter with your hand while smoking using the device?  
  
1 – Not at all 
2 – A little bit 
3 – A lot 
4 – As much as possible 
 
10. How easy or hard was the device to use?  
 
1 – Very easy 
2 –  Easy 
3 –  Neither easy nor hard 
4 – Hard 
5 – Very hard 
 
11. How “natural” did it feel to smoke through the machine?  
 
1 – Not at all 
2 – A little bit 
3 – A lot 
 
12. How much, if at all, did using the device change how you smoked a cigarette?  
  
1 – Not at all 
2 – A little bit 
3 – A lot 
 
13. What adjustments to your smoking, if any, did you make when smoking through the 
machine?  
Please describe:  ____________________________________________________ 
   ____________________________________________________ 
   ____________________________________________________ 
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14. I’d like you to please show me how you held the device when you used it to smoke. Please 
place a cigarette in the device and show me how you would puff.  
  
Note filter coverage/blocking: 
 
1 – Yes 
2 – No  
 
15. Did you try to hold the cigarette at all while using the device?  
 
1 – Not at all 
2 – Sometimes 
3 – All the time 
 
Additional questions to be completed only during the final visit by “switcher”, following Trial 3. 
 
16. How different, if at all, did you find smoking another brand?  
  
1 – Not at all 
2 – A little bit 
3 – A lot 
 
17. How much, if at all, did switching brands change how you smoked a cigarette?  
  
1 – Not at all 
2 – A little bit 
3 – A lot 
 
18. What adjustments to your smoking, if any, did you make after switching brands?  
 
Please describe:  ____________________________________________________ 
   ____________________________________________________ 









7.4 APPENDIX D: CReSSmicro Calibration Protocol 
 
Machine Number: ____________________  Status: Pre-Trial / Post-Trial 
Subject ID Number: __________________ Scale Factor: _________ 
 
 











 20 ml 25 ml/sec   
 20 ml 25 ml/sec   
 20 ml 25 ml/sec   
 20 ml 40 ml/sec   
 20 ml 40 ml/sec   
 20 ml 40 ml/sec   
 20 ml 55 ml/sec   
 20 ml 55 ml/sec   















 35 ml 25 ml/sec   
 35 ml 25 ml/sec   
 35 ml 25 ml/sec   
 35 ml 40 ml/sec   
 35 ml 40 ml/sec   
 35 ml 40 ml/sec   
 35 ml 55 ml/sec   
 35 ml 55 ml/sec   
 35 ml 55 ml/sec   
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Calibration Protocol cont. 
 
 











 50 ml 25 ml/sec   
 50 ml 25 ml/sec   
 50 ml 25 ml/sec   
 50 ml 40 ml/sec   
 50 ml 40 ml/sec   
 50 ml 40 ml/sec   
 50 ml 55 ml/sec   
 50 ml 55 ml/sec   
 50 ml 55 ml/sec   
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7.5 APPENDIX E: Daily Diary 
 
        
 
Daily Smoking Diary 
 
    Day 1: Monday, March 31st   
 
 
1. In total, how many cigarettes did you smoke?      ________ 
 
   
2. How many cigarettes did you smoke through the the hand-held device:  ________ 
 
 
3. How many cigarettes did you smoke not using the machine?   ________  
 
 
4. What time of day did you smoke your first cigarette after waking?   ________ 
 
 
5. What time of day did you smoke your last cigarette of the day?   ________ 
 
 










(Please write any comments for the day here) 
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Matinee Extra Mild King 0.1 76 24 
DuMaurier Edition Regular 0.4 64 36 
DuMaurier Ultra LIght Regular  0.6 56 44 
Benson & Hedges Special King  0.7 52 48 
DuMaurier Light Regular  0.8 48 52 
DuMaurier Special Mild  0.9 44 56 
Players Extra Light Regular  0.9 44 56 
Players Light Smooth Regular  0.9 44 56 
Export "A" Extra Light Regular  0.9 44 56 
Players Light Regular  0.9 44 56 
DuMaurier Regular  1.0 40 60 
Craven A Light Regular 1.0 40 60 
DuMaurier Light King  1.0 40 60 
Number 7 Light King  1.0 40 60 
Export "A" Light Regular  1.1 36 64 
DuMaurier King  1.1 36 64 
Players Light King  1.1 36 64 
Export "A" Medium Regular  1.1 36 64 
Rothmans King Size 1.2 32 68 
Craven "A" Regular Size 1.2 32 68 
Export "A" Regular Size 1.3 28 72 
  
*Note: Vent blocking =50%, Puff duration=2 seconds, and Butt length=Tipping + 3mm / 
23mm for all brands. 
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7.7 APPENDIX G: “Human mimic” Testing Parameters  
 





Matinee Extra Mild King 58 29 1.5 
DuMaurier Edition Regular 47 23 1.2 
DuMaurier Ultra LIght 
Regular  54 32 1.5 
Benson & Hedges Special 
King  65 24 1.7 
DuMaurier Light Regular  62 35 1.7 
DuMaurier Special Mild  54 31 1.4 
Players Extra Light Regular  57 25 1.6 
Players Light Smooth Regular  58 34 1.2 
Export "A" Extra Light  58 27 1.6 
Players Light Regular  66 50 1.6 
DuMaurier Regular  48 47 1.4 
Craven A Light Regular 54 33 1.4 
DuMaurier Light King  45 23 1.3 
Number 7 Light King  43 84 1.3 
Export "A" Light Regular  52 27 1.3 
DuMaurier King  42 32 1.2 
  
*Note: Vent blocking =50% and Butt length=Tipping + 3mm / 23mm for all brands. 
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7.8 APPENDIX H: Predictors of Salivary Cotinine (Trial 1) 
 
 
Linear Regression (n=41) 
 
Step 1: Main effects only 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  0.18 1.15 0.26 0.18 
Cigarettes per Day (CPD) 0.34 2.19 0.04 0.33 
Gender 
 (Male=reference) 0.16 1.05 0.30 0.16 
Smoke Intake per cigarette  0.28 1.81 0.08 0.28 
     
* Standardized beta  R2=.21, p = .08 
 
 
Step 2: Main effects + Interaction term 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  -0.86 -2.56 0.02 -0.34 
Gender 
 (Male=reference) 
0.34 2.36 0.02 0.31 
Cigarettes per Day (CPD) 0.47 3.32 0.00 0.44 
Smoke Intake per cigarette  -1.21 -2.63 0.01 -0.35 
CPD x Smoke Intake Saliva 1.95 3.38 0.00 0.45 
     








Appendix H continued 
 
Step 3a: Main effects + Interaction term + ISO Nicotine Yields 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  0.46 3.42 0.00 0.44 
Gender 
 (Male=reference) 0.33 2.39 0.02 0.31 
Cigarettes per Day (CPD) -1.17 -2.65 0.01 -0.34 
Smoke Intake per cigarette  -0.77 -2.35 0.03 -0.30 
CPD x Smoke Intake  1.85 3.31 0.00 0.43 
ISO Nicotine Yield 0.25 1.89 0.07 0.24 
     





Step 3b: Main effects + Interaction term + Massachusetts Nicotine Yields 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  0.41 2.84 0.01 0.38 
Gender 
 (Male=reference) 0.30 2.06 0.05 0.28 
Cigarettes per Day (CPD) -1.18 -2.48 0.02 -0.33 
Smoke Intake per cigarette  -0.89 -2.57 0.01 -0.35 
CPD x Smoke Intake  1.90 3.18 0.00 0.43 
Massachusetts Nicotine Yield 0.11 0.78 0.44 0.10 
     






Appendix H continued 
 
 
Step 3c: Main effects + Interaction term + Canadian Nicotine Yields 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  0.44 3.15 0.00 0.42 
Gender 
 (Male=reference) 0.32 2.17 0.04 0.29 
Cigarettes per Day (CPD) -1.22 -2.67 0.01 -0.35 
Smoke Intake per cigarette  -0.87 -2.60 0.01 -0.34 
CPD x Smoke Intake  1.93 3.37 0.00 0.45 
Canadian Nicotine Yield 0.17 1.21 0.23 0.16 
     




Step 3d: Main effects + Interaction term + Compensatory Nicotine Yields 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  0.44 3.19 0.00 0.42 
Gender 
 (Male=reference) 0.30 2.11 0.04 0.28 
Smoke Intake per cigarette  -1.00 -3.03 0.00 -0.40 
Cigarettes per Day (CPD) -1.41 -3.03 0.00 -0.40 
CPD x Smoke Intake  2.21 3.83 0.00 0.50 
Compensatory Nicotine Yield -0.23 -1.62 0.12 -0.21 
     










Step 3e: Main effects + Interaction term + Human Mimic Nicotine Yields 
Variable Beta* t value P value Part Correlation 
     
Collection Time of Day  -1.15 -3.45 0.00 -0.43 
Gender 
 (Male=reference) 0.35 2.59 0.01 0.32 
Cigarettes per Day (CPD) 0.55 4.06 0.00 0.50 
Smoke Intake per cigarette  -1.35 -3.13 0.00 -0.39 
CPD x Smoke Intake  2.17 4.00 0.00 0.50 
Human Mimic Nicotine Yield 0.37 2.51 0.02 0.31 
     
* Standardized beta  R2=.51, p < .001 
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Cotinine .09 -.09 .21 .08 .19 .31* .29* -.01 .06 .34** .03 .01 
N=42  * p <.10 **p<.05 ***p<.01  
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Cotinine .09 -.09 .21 .08 .19 .12 .25* .04 -.06 .01 -.05 .08 
n=42  * p <.10 **p<.05 ***p<.01  
 110














































.43*** .36** .41*** -- -- -- -- -- -- -- -- -- 
Puff Freq. 
(Cress) .59*** .61*** .30* -.08 -- -- -- -- -- -- -- -- 
Butt 
Length .04 .04 -.02 -.05 .07 -- -- -- -- -- -- -- 
Strongly 
Inhale .13 .15 .07 .02 .18 .06 -- -- -- -- -- -- 
Puff #  
(scale) .24 .31* .09 .00 .11 .28** .08 -- -- -- -- -- 
Puff # 
(open) .01 .02 .10 -.17 .24 .14 .02 .38*** -- -- -- -- 
Deeply 
Inhale .28* .32** .18 .05 .33** .33** .15 .39*** .46*** -- -- -- 
Puff Freq. .15 .16 .20 .10 .25 .11 .27* .17 .01 .11 -- -- 
Put down 
cig .00 .07 -.06 .11 .19 -.10 .25* -.26* -.16 -.16 .03 -- 
Cotinine -.09 -.09 .08 .16 .24 -.14 -.25* .20 -.02 -.06 .04 -.15 
n=42  * p <.10 **p<.05 ***p<.01 
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7.11 APPENDIX K: ITC Sample Characteristics 
 
Wave 2 Characteristics of ITC Sample, by Country (n=7,802) 
 CAN US UK AUS Total 
      
Sex      
Female 47.1 46.1 50.4 45.1 47.2 
Male 52.9 53.9 49.6 54.9 52.8 
      
Age      
18-24 13.8 15.3 15.4 15.8 15.1 
25-39 32.7 30.0 31.1 35.2 32.3 
40-54 36.0 36.1 30.1 33.5 33.9 
55+ 17.5 18.7 23.4 15.6 18.8 
      
Education      
12 years or less 45.4 41.3 61.6 61.3 53.9 
More than 12 years 54.6 58.7 38.4 32.7 46.1 
      
Ethnicity/Language      
White/English only 88.3 75.9 95.2 87.0 86.8 
Other/Mixed 11.7 24.1 4.8 13.0 13.2 
      
Income      
Low 28.6 35.2 27.5 26.0 29.2 
Medium 34.5 36.6 34.1 34.7 64.2 
High 28.6 21.8 30.3 33.2 28.6 
      
Intention to Quit      
No Intention 24.7 31.1 38.2 27.8 30.2 
Intention 75.3 68.9 61.8 72.2 69.8 
      












*CPD=Cigarettes per day 
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Linear regression: Predictors of self-reported Butt Length (n= 7,532) 
 
 Beta* t value p value Part r 
Sex 
(Male=reference) 
-.01 -.26 .80 -.01 
Income -.01 -.79 .42 -.01 
Age -.09 -6.1 <.001 -.09 
Ethnicity .01 .56 .58 .01 
CPD .14 9.6 <.001 .14 
RYO cigarette -.01 -.81 .42 -.01 
Intention to quit -.02 -.86 .39 -.01 
Education  -.03 -2.69 .001 -.03 
Country (CAN =Reference)    
US  -.09 -5.2 <.001 -.08 
UK -.10 -5.4 <.001 -.08 
AUS .03 -1.5 .14 -.02 
 
 * Standardized Beta   R2= .05, p<.001 
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Linear regression: Predictors of self-reported Puff Strength (n= 7,505) 
 
 Beta* t value p value Part r 
Sex 
(Male=reference) 0.01 0.51 0.61 0.01 
Income -0.01 -0.83 0.41 -0.01 
Age -0.10 -8.12 <.001 -0.09 
Ethnicity 0.01 1.04 0.30 0.01 
CPD 0.16 13.75 <.001 0.15 
RYO cigarette -0.02 -1.75 0.08 -0.02 
Intention to quit -0.08 -6.94 <.001 -0.08 
Education  -0.04 -3.26 0.001 -0.04 
Country (CAN =Reference)    
US  -0.09 -6.84 <.001 -0.08 
UK -0.09 -6.10 <.001 -0.07 
AUS -0.02 -1.15 0.25 -0.01 
 * Standardized Beta   R2= .09, p<.001 
 114




Linear regression: Predictors of self-reported Puff Number (n=7,448) 
 
 Beta* t value p value Part r 
Sex 
(Male=reference) 0.01 0.76 0.45 0.01 
Income -0.03 -2.31 0.02 -0.03 
Age -0.10 -8.88 <.001 -0.10 
Ethnicity -0.01 -0.88 0.38 -0.01 
CPD 0.18 15.53 <.001 0.18 
RYO cigarette 0.00 0.18 0.85 0.00 
Intention to quit -0.05 -4.04 <.001 -0.05 
Education  0.00 0.14 0.88 0.00 
Country (CAN =Reference)    
US  0.01 0.36 0.72 0.01 
UK -0.06 -4.48 <.001 -0.05 
AUS -0.02 -1.69 0.09 -0.02 
 
 * Standardized Beta   R2= .06, p<.001 
 
 115





Linear regression: Predictors of self-reported Puff frequency (n=7,415) 
 
 Beta* t value p value Part r 
Sex 
(Male=reference) .03 1.85 .06 .03 
Income -.01 -.27 .79 -.01 
Age -.16 -10.22 <.001 -.15 
Ethnicity -.04 -2.69 .007 -.04 
CPD .07 4.57 <.001 .07 
RYO cigarette -.02 -1.29 -.20 -.02 
Intention to quit -.01 -.53 -.59 -.01 
Education  .02 1.42 .16 .02 
Country (CAN =Reference)    
US  .01 .61 .54 .01 
UK .04 1.91 .06 .03 
AUS .08 4.52 <.001 .07 
 
 * Standardized Beta   R2= .03, p<.001 
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Linear regression: Predictors of Wave 2-Wave 3 Changes in Puff Strength 
(n=4,314) 
 
 Beta* t value p value Part r 
Sex 
(Male=reference) 0.00 0.17 0.87 0.00 
Income 
0.02 1.16 0.25 0.02 
Age 
-0.01 -0.90 0.37 -0.01 
Ethnicity 
-0.01 -0.55 0.58 -0.01 
CPD change 
0.01 0.63 0.53 0.01 
RYO cigarette 
-0.01 -0.69 0.49 -0.01 
Intention to quit 
-0.01 -0.42 0.67 -0.01 
Education  
0.00 -0.25 0.81 0.00 
Country (CAN =Reference)    
US  
0.00 -0.05 0.96 0.00 
UK 
-0.03 -1.77 0.08 -0.03 
AUS 
-0.04 -2.17 0.03 -0.03 
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